<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night PYQ (INICET, PSM-1) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  background: url("assets/background.jpg") center center / cover no-repeat fixed;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
}

body::before {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
  
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
  
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* Responsive utilities */
@media (max-width: 768px) {
  .glass-card {
    border-radius: 16px;
  }
  
  .glass {
    border-radius: 12px;
  }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Late Night PYQ INICET
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">75</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="flex container mx-auto px-6 gap-8">
        <!-- Question Navigation Sidebar -->
        <div class="w-80 glass p-6 h-fit sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="flex-1 max-w-4xl">
            <div class="glass-card p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <!-- Explanation Video -->
                    <div id="solutionVideo" class="hidden">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

    <script>
        let questionsData = [
  {
    "id": 11055,
    "choices": [
      {
        "id": 44186,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">3 &gt;2&gt;1</span></p>"
      },
      {
        "id": 44187,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">3&gt;1&gt;2</span></p>"
      },
      {
        "id": 44188,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">1&gt;2&gt;3</span></p>"
      },
      {
        "id": 44189,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">1=2=3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">As a medical student, you're learning about the margin of error and its relationship with sample size. With three studies of different sizes (Sample 1: 1000, Sample 2: 800, Sample 3: 600), how would you order the expected margins of error from largest to smallest? </span><span style=\"color:black;font-size:12.0pt;\">(AIIMS MAY 2018)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip8.jpg\" alt=\"\" width=\"572\" height=\"333\"></p>",
    "unique_key": "Q2081991",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305491,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. A) 3&gt;2&gt;1</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Curve 1 exhibits the smallest margin of error, followed by Curve 2, and then Curve 3. Thus, the ranking is as follows: 3&gt;2&gt;1.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The depicted image showcases three normal distribution curves with varying sample sizes, all sharing the same mean but differing in standard deviation.</span></li><li><span style=\"color:black;font-size:12.0pt;\">When the sample size decreases, the peak diminishes, and the curve adopts a flatter shape.</span></li><li><span style=\"color:black;font-size:12.0pt;\">This signifies a broader confidence interval for the specified mean.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The width of the curve's base is directly linked to the margin of error.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The margin of error in a study is inversely related to the square root of the sample size.</span></li><li><span style=\"font-size:12.0pt;\">This relationship implies that a larger sample size will generally lead to a smaller margin of error, assuming other variables like variance remain constant.</span></li></ul>",
    "correct_choice_id": 44186,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "ImageBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 11060,
    "choices": [
      {
        "id": 44206,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Mean &gt; Median &gt; Mode</span></p>"
      },
      {
        "id": 44207,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Mode &gt; Median &gt; Mean</span></p>"
      },
      {
        "id": 44208,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Mode = Mean = Median</span></p>"
      },
      {
        "id": 44209,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Peaked symmetrical distribution</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">Given the particular appearance and characteristics of the box-whisker plot as shown below, which of the following statements most accurately describes the relationships between the mean, median, and mode? (AIIMS MAY 2018)&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip9.jpg\" alt=\"\" width=\"200\" height=\"336\"></p>",
    "unique_key": "Q3974397",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305496,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans.&nbsp;A) Mean &gt; Median &gt; Mode&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">The provided box-whisker plot illustrates a distribution that is positively skewed (right skewed).</span></li><li><span style=\"color:black;font-size:12.0pt;\">In a positively skewed distribution, the mean &gt; median &gt; mode.</span></li><li><span style=\"color:black;font-size:12.0pt;\">To further understand and correlate the fact, have a look at the following images:</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture8222.jpg\" alt=\"\" width=\"900\" height=\"337\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In Right skew curve: Mean &gt; Median &gt; Mode</span></li><li><span style=\"font-size:12.0pt;\">In Left skew curve: Mean &lt; Median &lt; Mode</span></li><li><span style=\"font-size:12.0pt;\">In Normal distribution: Mean = Median = Mode.</span></li></ul>",
    "correct_choice_id": 44206,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 57610,
    "choices": [
      {
        "id": 229809,
        "text": "<p><span style=\"font-size:12.0pt;\">5 days</span></p>"
      },
      {
        "id": 229810,
        "text": "<p><span style=\"font-size:12.0pt;\">10 days</span></p>"
      },
      {
        "id": 229811,
        "text": "<p><span style=\"font-size:12.0pt;\">14 days</span></p>"
      },
      {
        "id": 229812,
        "text": "<p><span style=\"font-size:12.0pt;\">20 days</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An infectious disease has its incubation period as 5-14 days, with its median incubation period being 10 days. The quarantine of contacts traveling to a new country should be done for: (NEET PG 2024)</span></p>",
    "unique_key": "Q6509764",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305547,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 14 days</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Quarantine is the process of separating and restricting the movement of healthy individuals who may have been exposed to an infectious disease, to prevent its spread. <strong>Quarantine is typically implemented for the maximum incubation period of the disease</strong>, which is the time between exposure to the infection and the onset of symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case, the maximum incubation period is 14 days. Therefore, quarantine should be conducted for 14 days to ensure that if symptoms develop, they will appear within this period, confirming the need for isolation and treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Quarantine should be conducted for the maximum incubation period of the infectious disease to ensure that symptoms will manifest within that time, confirming whether a contact becomes a case.</span></p>",
    "correct_choice_id": 229811,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 57608,
    "choices": [
      {
        "id": 229801,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dedication</span></span></span></p>"
      },
      {
        "id": 229802,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Action</span></span></span></p>"
      },
      {
        "id": 229803,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Contemplation</span></span></span></p>"
      },
      {
        "id": 229804,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reflection</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For Health Education, the Motivation Model has its 1<sup>st</sup> &nbsp;Step as Awareness. Its 2<sup>nd</sup> &nbsp;Step is Motivation. Its 3<sup>rd</sup> &nbsp;Step is:</span><span style=\"font-size:12.0pt\"> (NEET PG 2024)</span></span></span></p>",
    "unique_key": "Q6539771",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305549,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Action</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Motivation Model for Health Education comprises three steps:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Awareness</span></strong><span style=\"font-size:12.0pt\">: This step involves generating <strong>interest </strong>in the person&rsquo;s mind about the health topic or problem.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Motivation</span></strong><span style=\"font-size:12.0pt\">: This stage includes <strong>evaluation and decision-making</strong>, where the person is encouraged and motivated to consider the health information or behavior change.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Action</span></strong><span style=\"font-size:12.0pt\">: This is the final step where the individual <strong>accepts and adopts</strong> the health idea or practice. The person moves from motivation to implementation, engaging in the recommended health behavior.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other 2 Models are &ndash; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Medical Model &ndash; </span></strong><span style=\"font-size:12.0pt\">This involves interaction between the patient and doctor, where the patient presents their illness, and the doctor diagnoses it as a disease.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Social Interactive Model </span></strong></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Dedication</span></strong><span style=\"font-size:12.0pt\">: Dedication is not explicitly a step in the Motivation Model but can be an outcome of sustained action and commitment to the behavior change.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Contemplation</span></strong><span style=\"font-size:12.0pt\">: Contemplation is a stage in other health behavior change models, such as the Transtheoretical Model, where individuals consider changing but do not yet take action. It is not the third step in the Motivation Model.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Reflection</span></strong><span style=\"font-size:12.0pt\">: Reflection is not part of the Motivation Model&rsquo;s steps. It typically refers to thinking back on actions and decisions, often occurring after the behavior has been implemented.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The third step in the Motivation Model for Health Education is <strong>Action</strong>, which signifies the adoption and implementation of the health behavior.</span></span></p>",
    "correct_choice_id": 229802,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11059,
    "choices": [
      {
        "id": 44202,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">BCG, OPV 1st dose, Pentavalent 1st dose, Rota virus 1st dose</span></p>"
      },
      {
        "id": 44203,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">OPV 1st dose, Pentavalent 1st dose, Measles 1st dose</span></p>"
      },
      {
        "id": 44204,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">BCG, OPV 1st dose, Measles 1st dose</span></p>"
      },
      {
        "id": 44205,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">OPV 1st dose, DPT 1st dose, Measles 1st dose</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">As a Medical Officer at a Community Health Center (CHC), you're consulted by a mother about starting immunizations for her 13-month-old son who hasn't received any vaccines since birth. Based on the national immunization schedule, which combination of vaccines would you recommend for this child's initial immunization? </span><span style=\"color:black;font-size:12.0pt;\">(AIIMS MAY 2018)</span></p>",
    "unique_key": "Q5383011",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305495,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) OPV 1st dose, DPT 1st dose, Measles 1st dose</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">DPT-1, OPV-1 and Measles 1st dose will be given to this child.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Age Limits for Delayed Immunization in NIS, India</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture62222.jpg\" alt=\"\" width=\"800\" height=\"535\"></span></p>",
    "correct_choice_id": 44205,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 57611,
    "choices": [
      {
        "id": 229813,
        "text": "<p><span style=\"font-size:12.0pt;\">Incubation period</span></p>"
      },
      {
        "id": 229814,
        "text": "<p><span style=\"font-size:12.0pt;\">Median IP</span></p>"
      },
      {
        "id": 229815,
        "text": "<p><span style=\"font-size:12.0pt;\">Serial IP</span></p>"
      },
      {
        "id": 229816,
        "text": "<p><span style=\"font-size:12.0pt;\">Generation time</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The time gap between entry of organism in human body and its maximal infectivity is: (NEET PG 2024)</span></p>",
    "unique_key": "Q5935332",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305546,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Generation time</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Generation time is defined as the time interval between the entry of an infectious organism into the human body and the period when the individual reaches maximal infectivity. This concept is crucial in understanding the spread of infectious diseases, as it indicates when an infected person is most likely to transmit the infection to others.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Generation time helps public health professionals predict the spread of disease and is essential in planning control measures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Incubation period: </strong>This option is incorrect. The incubation period is the time from exposure to the onset of first sign/symptom, not specifically related to the peak of infectivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Median IP: </strong>This option is incorrect. Median incubation period refers to the time by which 50% of cases exhibit symptoms, unrelated to infectivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp; Serial IP (Serial Interval Period): </strong>This option is incorrect. The serial interval measures the gap between symptom onset in a primary case and a secondary case, not between entry of the organism and peak infectivity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Generation time is the interval between the entry of an organism into the body and the point of maximal infectivity.</span></p>",
    "correct_choice_id": 229816,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11053,
    "choices": [
      {
        "id": 44178,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Response- Mitigation- Reconstruction- Rehabilitation- Preparedness</span></span></span></span></p>"
      },
      {
        "id": 44179,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Mitigation- Rehabilitation- Reconstruction- Preparedness- response</span></span></span></span></p>"
      },
      {
        "id": 44180,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Response- Rehabilitation- Reconstruction- Mitigation- Preparedness</span></span></span></span></p>"
      },
      {
        "id": 44181,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Mitigation- Preparedness- Reconstruction- Rehabilitation- Response</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As a physician on a disaster preparedness committee in a region prone to natural disasters, you are discussing the appropriate sequence of actions following a disaster. </span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Which of the following sequences correctly represents the appropriate steps in disaster management after the event has taken place? (AIIMS MAY 2018)</span></span></span></p>",
    "unique_key": "Q1160149",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305489,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">&nbsp;<strong>Ans. C) Response &ndash; Rehabilitation &ndash; Reconstruction &ndash; Mitigation &ndash; Preparedness</strong></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The correct sequence after a disaster as per the general disaster management principles is:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Response:</span></strong><span style=\"font-size:12.0pt\"> Immediate actions taken to ensure safety, provide emergency services, and stabilize the situation. This involves &ndash; </span></span></span></li>\r\n</ol>\r\n\r\n<ul style=\"margin-left:40px\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Search, rescue and first aid</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Field care</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Triage</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tagging</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Identification of dead</span></span></span></li>\r\n</ul>\r\n\r\n<ol start=\"2\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Rehabilitation:</span></strong><span style=\"font-size:12.0pt\"> Short-term recovery and normalization of operations to restore basic services and functions in the affected area.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Reconstruction:</span></strong><span style=\"font-size:12.0pt\"> Long-term rebuilding of infrastructure and restoration of a fully functional community.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mitigation:</span></strong><span style=\"font-size:12.0pt\"> Efforts to reduce the risk and lessen the impact of future disasters.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Preparedness:</span></strong><span style=\"font-size:12.0pt\"> Planning and preparation to improve response activities for future disasters.</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Disaster Cycle</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/whatsapp-image-2023-10-20-at-173957.jpeg\" style=\"height:534px; width:500px\" /></span></span></span></span></p>",
    "correct_choice_id": 44180,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "Factual"
    ]
  },
  {
    "id": 10199,
    "choices": [
      {
        "id": 40762,
        "text": "<p><span style=\"font-size:12.0pt;\">Oral amoxicillin for five days</span></p>"
      },
      {
        "id": 40763,
        "text": "<p><span style=\"font-size:12.0pt;\">Urgent referral to the tertiary care centre immediately</span></p>"
      },
      {
        "id": 40764,
        "text": "<p><span style=\"font-size:12.0pt;\">Administer IV antibiotics and ask the patient to be brought after 24 hours</span></p>"
      },
      {
        "id": 40765,
        "text": "<p><span style=\"font-size:12.0pt;\">Start antipyretics urgently</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 2-year-old toddler with a weight of 11 kg was brought to the pediatric outpatient department. The child exhibited a respiratory rate of 38 breaths per minute and upon examination, noticeable chest indrawing was detected. What is the next step of management? (NEET PG 2020)</span></p>",
    "unique_key": "Q2971493",
    "question_audio": null,
    "question_video": null,
    "map_id": 34307277,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Oral amoxicillin for five days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to the latest revised guidelines by WHO, the management of childhood pneumonia has been updated based on new evidence. In the given scenario, a 2-year-old child presents with a respiratory rate of 38 breaths per minute and chest indrawing, which fits the criteria for pneumonia but without general danger signs. According to the revised classification, the appropriate management for this case is oral amoxicillin for five days and home care advice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Urgent referral to the tertiary care centre immediately</strong>: This is recommended for children showing general danger signs or very severe disease, not for pneumonia with chest indrawing without other danger signs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Administer IV antibiotics and ask the patient to be brought after 24 hours</strong>: This would be applicable for severe cases requiring inpatient care, not for managing a case of pneumonia without general danger signs at an outpatient department.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Start antipyretics urgently</strong>: While antipyretics may be used to manage fever, they do not address the underlying pneumonia and are not the primary management step in this scenario.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-134019.jpg\" alt=\"\" width=\"800\" height=\"346\"></span></p>",
    "correct_choice_id": 40762,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 10211,
    "choices": [
      {
        "id": 40810,
        "text": "<p><span style=\"font-size:12.0pt;\">Cross sectional</span></p>"
      },
      {
        "id": 40811,
        "text": "<p><span style=\"font-size:12.0pt;\">Ecological</span></p>"
      },
      {
        "id": 40812,
        "text": "<p><span style=\"font-size:12.0pt;\">Experimental</span></p>"
      },
      {
        "id": 40813,
        "text": "<p><span style=\"font-size:12.0pt;\">Quasi-experimental</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An individual seeks to explore the correlation between smoking and lung cancer. To do so, they gather information on individuals diagnosed with lung cancer from government hospitals, along with data on the quantity of cigarette packets sold during the corresponding timeframe. What category of study does this represent? (NEET PG 2020)</span></p>",
    "unique_key": "Q2214278",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305527,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Ecological</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the given study, the unit of study is the population, and the data collected by the investigator is secondary in nature. Therefore, this type of study is an ecological study, also known as a correlational study.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Cross-Sectional Study: </strong>Involves collecting data at a single point in time from individuals to assess the prevalence of an outcome or characteristic.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The unit of analysis is the individual, not the population.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Experimental Study: </strong>Involves the researcher manipulating one or more variables to observe the effect on an outcome.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">There is no experimental intervention in the given study scenario.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Quasi-Experimental Study: </strong>Involves an intervention but lacks random assignment of participants to treatment or control groups.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Similar to experimental studies, quasi-experimental studies involve individuals, not population-level data.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>ECOLOGICAL STUDY / CO-RELATIONAL STUDY</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Done at a point of time [E.g. in 2023]</span></li><li><span style=\"font-size:12.0pt;\">Used in Nutritional surveys, e.g. \u00e0 Avg. fat intake = 20gm/day</span></li><li><span style=\"font-size:12.0pt;\">Can\u2019t calculate strength of Association or Prevalence</span></li><li><span style=\"font-size:12.0pt;\">Based on secondary data [collected by someone else, studied by investigator]</span></li></ul>",
    "correct_choice_id": 40811,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11081,
    "choices": [
      {
        "id": 44290,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Zidovudine + Lamivudine for 4 weeks</span></span></span></p>"
      },
      {
        "id": 44291,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lamivudine+ Tenofovir+ Dolutegravir for 4 weeks</span></span></span></p>"
      },
      {
        "id": 44292,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lamivudine+ Zidovudine + Efavirenz for 4 weeks</span></span></span></p>"
      },
      {
        "id": 44293,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Zidovudine + Lamivudine + Nevirapine for 4 weeks</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old resident physician was exposed to HIV through a needlestick injury and has come to the emergency department seeking help. You decide to start her on post-exposure prophylaxis (PEP). Which of the following drug combinations is most recommended for PEP in this scenario? (AIIMS MAY 2020)</span></span></p>",
    "unique_key": "Q9317586",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305517,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Lamivudine+ Tenofovir+ Dolutegravir for 4 weeks&nbsp;</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Post-exposure prophylaxis (PEP) is an emergency treatment for HIV exposure, typically recommended to be started as soon as possible after exposure, ideally within 2 hours and no later than 72 hours. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The choice of antiretroviral therapy for PEP should be guided by current recommendations that prioritize effectiveness and tolerability.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lamivudine + Tenofovir + Dolutegravir (Option B):</span></span></strong><span style=\"font-size:12.0pt\"> This combination is currently recommended for PEP due to its high efficacy, good tolerability, and strong safety profile. Tenofovir and Lamivudine provide a potent backbone of nucleoside reverse transcriptase inhibitors (NRTIs), while Dolutegravir acts as an integrase strand transfer inhibitor (INSTI), which has a rapid onset of action and is well-tolerated.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Post Exposure Prophylaxis HIV</span></u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Preferably within 24 hours. Maximum within 72 hours.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Duration of prophylaxis is 28 days</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/screenshot-2023-10-25-192252.jpg\" style=\"height:286px; width:700px\" /></span></span></span></p>",
    "correct_choice_id": 44291,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 11050,
    "choices": [
      {
        "id": 44166,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">I - A, II - B, III - C, IV - D</span></p>"
      },
      {
        "id": 44167,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">I - C, II - D, III - A, IV - B</span></p>"
      },
      {
        "id": 44168,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">I - D, II - C, III - A, IV - B</span></p>"
      },
      {
        "id": 44169,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">I - B, II - A, III - D, IV - C</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">During a medical ethics seminar, Dr. Sharma discussed a series of international declarations that guide medical professionals in upholding ethical principles in various scenarios. These declarations were born out of historical events and societal needs to ensure the welfare of patients and respect human rights. Can you match these declarations with their respective significance? (AIIMS MAY 2017)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-115842.png\" alt=\"\" width=\"1000\" height=\"307\"></p>",
    "unique_key": "Q6189208",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305487,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) I - C, II - D, III - A, IV - B</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Geneva Declaration:</strong> It is primarily focused on the physician's dedication to the humanitarian goals of medicine, emphasizing the commitment of the medical profession to human welfare and ethics. This declaration is assigned significance C.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Oslo Declaration:</strong> It deals with issues surrounding therapeutic abortion, offering guidelines and ethical considerations for medical professionals when abortion is a factor in medical treatment. This declaration is assigned significance D.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Tokyo Declaration:</strong> Provides guidelines for physicians concerning the ethical treatment of detainees and prisoners, specifically regarding torture and other forms of cruel, inhuman, or degrading treatment. This declaration is assigned significance A.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Helsinki Declaration:</strong> A cornerstone document that outlines ethical principles for the medical community concerning human experimentation. This declaration provides comprehensive guidelines intended to protect the dignity, rights, safety, and well-being of research subjects. It is assigned significance B.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-120210.png\" alt=\"\" width=\"1000\" height=\"319\"></p>",
    "correct_choice_id": 44167,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 11078,
    "choices": [
      {
        "id": 44278,
        "text": "<p><span style=\"font-size:12.0pt;\">LAQSHYA</span></p>"
      },
      {
        "id": 44279,
        "text": "<p><span style=\"font-size:12.0pt;\">Ayushman Bharat</span></p>"
      },
      {
        "id": 44280,
        "text": "<p><span style=\"font-size:12.0pt;\">Janani Shishu Suraksha Karyakram</span></p>"
      },
      {
        "id": 44281,
        "text": "<p><span style=\"font-size:12.0pt;\">Pradhan Mantri Surakshit Matritva Abhiyan</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">As a healthcare consultant in Uttar Pradesh working to improve maternal and child health outcomes, you need to address issues such as inadequate hygiene, lack of skilled staff, and outdated equipment in labor rooms of public health facilities. Which program should you recommend that is specifically designed to enhance the quality of labor rooms? (AIIMS MAY 2019)</span></p>",
    "unique_key": "Q3076361",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305514,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) LAQSHYA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">LAQSHYA [<strong>La</strong>bour Room <strong>Q</strong>uality Improvement Initiative]&nbsp;</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">MoHFW launched LaQshya to improve the quality of care that is being provided to the pregnant mother in the Labor Room and Maternity Operation Theaters, thereby preventing the undesirable adverse outcomes associated with childbirth</span></li><li><span style=\"font-size:12.0pt;\">Aim: To reduce Maternal and newborn mortality &amp; morbidity and stillbirths</span></li><li><span style=\"font-size:12.0pt;\">Coverage: Govt Medical colleges &amp; hospitals/District hospitals/FRU &gt; 100 deliveries/month, High load CHC (&gt;60 deliveries/month)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/picture12.jpg\" alt=\"\" width=\"500\" height=\"642\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ayushman Bharat</strong>: This is a broader health insurance scheme aimed at providing health cover to underprivileged families, not specifically focused on improving labor room conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Janani Shishu Suraksha Karyakram</strong>: Although this program provides free benefits to pregnant women and sick infants, it does not specifically target the improvement of labor room conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pradhan Mantri Surakshit Matritva Abhiyan</strong>: This initiative is aimed at providing assured, comprehensive, and quality antenatal care, free of cost, to pregnant women on the 9th of every month but does not specifically address labor room quality improvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Recommending the LAQSHYA program is directly aligned with the need to overhaul the quality of labor rooms in public health facilities, targeting specific improvements in infrastructure, hygiene, and staff competencies to ensure safer childbirth experiences.</span></li></ul>",
    "correct_choice_id": 44278,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 10203,
    "choices": [
      {
        "id": 40778,
        "text": "<p><span style=\"font-size:12.0pt;\">Decision making</span></p>"
      },
      {
        "id": 40779,
        "text": "<p><span style=\"font-size:12.0pt;\">Systems analysis</span></p>"
      },
      {
        "id": 40780,
        "text": "<p><span style=\"font-size:12.0pt;\">Network analysis</span></p>"
      },
      {
        "id": 40781,
        "text": "<p><span style=\"font-size:12.0pt;\">Management by objective</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of these methods relies on behavioral sciences? (NEET PG 2020)</span></p>",
    "unique_key": "Q1850488",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305534,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Management by objective</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Management by objective (MBO) is a technique based on behavioral sciences. It was developed by Peter Drucker in the 1950s and emphasizes the importance of setting clear goals and objectives that are aligned with organizational goals, and then measuring progress towards achieving those objectives.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">MBO is based on the idea that individuals are motivated by the achievement of goals and that they perform better when they know what is expected of them. The technique involves a participatory process where employees are involved in setting their own goals and objectives, which are then reviewed and evaluated by their managers. This approach is intended to improve communication and collaboration within organizations, and to help employees feel more engaged and motivated in their work.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A</strong>. <strong>Decision making:</strong> &nbsp;This can rely on both behavioral sciences and quantitative methods, but in the context of management and organizational processes, it often involves analytical and quantitative approaches.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Systems analysis:&nbsp;</strong> This is a quantitative method used to understand and analyze complex systems and processes, often involving mathematical models and simulations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> <strong>Network analysis:&nbsp;</strong> This is a quantitative method used to plan and control complex projects, involving techniques like PERT (Program Evaluation and Review Technique) and CPM (Critical Path Method).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-150243.png\" alt=\"\" width=\"1000\" height=\"338\"></strong></span></p>",
    "correct_choice_id": 40781,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11062,
    "choices": [
      {
        "id": 44214,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Sensitivity and specificity will increase</span></p>"
      },
      {
        "id": 44215,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Sensitivity will decrease, specificity will increase</span></p>"
      },
      {
        "id": 44216,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Sensitivity and specificity will decrease</span></p>"
      },
      {
        "id": 44217,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Sensitivity will increase, specificity will decrease</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">You are assessing the impact of a new series testing protocol on the performance characteristics of diagnostic tests for a specific disease. You need to explain to your team how this method affects the test's sensitivity and specificity. What would be the correct explanation? (</span>AIIMS May 2018)</p>",
    "unique_key": "Q8204963",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305498,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) Sensitivity will decrease, specificity will increase</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>SCREENING TESTS USED IN SERIES:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">A population is subjected to one screening test followed by a second screening test; 2nd screening test is applied on those individuals only who test positive on the 1st screening test</span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Combined sensitivity of 2 tests A &amp; B in series: Sensitivity (A) \u00d7 Sensitivity (B)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Combined specificity of 2 tests A &amp; B in series: [Specificity (A) + Specificity (B)] \u2013 [Specificity (A) \u00d7 Specificity (B)]</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>SCREENING TESTS USED IN PARALLEL:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">A population is subjected to two (or more) screening tests at the same time; each of the individuals is subjected to both (or all) screening tests</span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Combined sensitivity of 2 tests A &amp; B in parallel: [Sensitivity (A) + Sensitivity (B)] \u2013 [Sensitivity (A) \u00d7 Sensitivity (B)]</span></li><li><span style=\"color:black;font-size:12.0pt;\">Combined specificity of 2 tests A &amp; B in parallel: Specificity (A) \u00d7 Specificity (B)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/screenshot-2023-10-20-165555.jpg\" alt=\"\" width=\"800\" height=\"341\"></span></p>",
    "correct_choice_id": 44215,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 11067,
    "choices": [
      {
        "id": 44234,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Epidemic</span></p>"
      },
      {
        "id": 44235,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Endemic</span></p>"
      },
      {
        "id": 44236,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Sporadic</span></p>"
      },
      {
        "id": 44237,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Outbreak</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">As the in-charge epidemiologist of an urban CHC, you've been reviewing the weekly infectious disease reports. In a particular community under your jurisdiction, you observe that dengue case counts typically range from 40 to 50 cases every week. During your current weekly review, you note there are 48 reported cases of dengue. Based on this data and your understanding of epidemiological terminology, how would you classify this week's situation with respect to dengue? (AIIMS MAY 2018)</span></p>",
    "unique_key": "Q8932902",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305503,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) Endemic&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">The given scenario is an example of an endemic disease.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Endemic</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Endemic: Constant presence of a disease or infectious agent in a defined geographical area. It is the \u2018usual or expected frequency\u2019 of a disease in a population</span></li><li><span style=\"color:black;font-size:12.0pt;\">Types of Endemic:</span><ul style=\"list-style-type:circle;\"><li><span style=\"color:black;font-size:12.0pt;\">Hyper-endemic: Constant presence of a disease or infectious agent at high incidence/prevalence AND affects all age groups equally</span></li><li><span style=\"color:black;font-size:12.0pt;\">Holo-endemic: A high level of infection beginning early in life AND affecting most of the children population</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Epidemic:</strong> Incorrect because an epidemic refers to an increase in the number of cases of a disease beyond what is normally expected in that population in that area. The current case count does not exceed the usual range.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Sporadic:</strong> Incorrect because sporadic refers to a disease that occurs infrequently and irregularly; here, the cases are neither infrequent nor irregular.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Outbreak:</strong> Similar to an epidemic, an outbreak implies a greater-than-anticipated increase in the number of cases within a small, localized area over a short period. Again, since the case count is within normal expectations, this term does not apply.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Endemic: Is the \u2018usual or expected frequency\u2019 of a disease in a population</span></li></ul>",
    "correct_choice_id": 44235,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 11033,
    "choices": [
      {
        "id": 44098,
        "text": "<p style=\"margin-right:44px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Not more than 10% of the people benefitted by the drug could be due to chance</span></span></span></span></p>"
      },
      {
        "id": 44099,
        "text": "<p style=\"margin-right:91px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">90% of patients will be benefitted by giving the drug</span></span></span></span></p>"
      },
      {
        "id": 44100,
        "text": "<p style=\"margin-right:91px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The test is 90% reproducible</span></span></span></span></p>"
      },
      {
        "id": 44101,
        "text": "<p style=\"margin-right:90px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">90% of test results could have occurred by chance</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">An investigative study was conducted in Mumbai wherein a promising new antihypertensive medication was evaluated for its potential efficacy. Initial clinical trials with a diverse cohort of patients with chronic hypertension revealed promising results in managing elevated blood pressure levels. The efficacy of the drug was measured meticulously, and upon analyzing the data, a p-value of &lt; 0.10 was documented. Given this statistical information and considering the nuances of research interpretation, which of the following statements best elucidates the implications of this p-value in terms of the drug&#39;s effect? (AIIMS MAY 2017)</span></span></span></p>",
    "unique_key": "Q1823901",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305477,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A) Not more than 10% of the people benefitted by the drug could be due to chance</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">A P-value of less than 0.10 suggests that the likelihood of the drug&#39;s benefits occurring due to chance is no higher than 10%.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">&nbsp;INTERPRETATION:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Out of 100 repeated tests, a statistically insignificant difference will occur only 10 times, while a statistically significant difference will emerge 90 times.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">There is a 10% probability of incorrectly concluding that a drug is beneficial when it is not, which can happen in statistical studies when deciding whether to accept or reject a null hypothesis.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The P value is compared to a predetermined threshold value &#39;a&#39;; if the P value is less than &#39;a&#39;, the test is considered statistically significant, and the null hypothesis is rejected.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The p-value is a statistical parameter used to evaluate whether the results of an experiment are statistically significant. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In this case, a p-value of &lt; 0.10 suggests there is up to a 10% chance that the observed benefits from the antihypertensive drug could be due to random variation rather than a true effect of the drug.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 44098,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 10206,
    "choices": [
      {
        "id": 40790,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypertriglyceridemia</span></p>"
      },
      {
        "id": 40791,
        "text": "<p><span style=\"font-size:12.0pt;\">High LDL</span></p>"
      },
      {
        "id": 40792,
        "text": "<p><span style=\"font-size:12.0pt;\">Central obesity</span></p>"
      },
      {
        "id": 40793,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypertension</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">According to NCEP-ATP III guidelines, which of the options below is not considered a criterion for metabolic syndrome? (NEET PG 2020)</span></p>",
    "unique_key": "Q3088207",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305532,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) High LDL</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>High LDL:</strong> This is not a criterion for metabolic syndrome according to the NCEP-ATP III guidelines. While high LDL cholesterol is a significant risk factor for cardiovascular disease, it is not part of the metabolic syndrome criteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Hypertriglyceridemia:</strong> Elevated triglyceride levels are a criterion for metabolic syndrome and indicate dyslipidemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> <strong>Central Obesity:</strong> Defined by waist circumference, this is a key criterion for metabolic syndrome and indicates visceral fat accumulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Hypertension:</strong> Elevated blood pressure is included in the criteria for metabolic syndrome, reflecting its association with increased cardiovascular risk.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to NCEP-ATP III guidelines, criterion for metabolic syndromes are:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-150730.png\" alt=\"\" width=\"1000\" height=\"905\"></span></p>",
    "correct_choice_id": 40791,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10216,
    "choices": [
      {
        "id": 40830,
        "text": "<p><span style=\"font-size:12.0pt;\">Relative risk</span></p>"
      },
      {
        "id": 40831,
        "text": "<p><span style=\"font-size:12.0pt;\">Attributable</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">risk</span></p>"
      },
      {
        "id": 40832,
        "text": "<p><span style=\"font-size:12.0pt;\">Population</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Attributable</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">risk</span></p>"
      },
      {
        "id": 40833,
        "text": "<p><span style=\"font-size:12.0pt;\">Odds Ratio</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following variables indicates the difference between the incidence of disease among exposed and incidence among non-exposed? (NEET PG 2020)</span></p>",
    "unique_key": "Q3871165",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305524,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Attributable risk</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The difference between the incidence of disease among exposed and the incidence among non-exposed is given by the attributable risk. Attributable risk is the difference in risk of disease between two groups (exposed and non-exposed) and represents the proportion of disease occurrence that can be attributed to the exposure.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-173720_vY5TP7I.jpg\" alt=\"\" width=\"811\" height=\"66\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp; Relative risk:&nbsp;</strong>Is a measure of the strength of association between exposure and disease, and it compares the risk of disease in exposed individuals to the risk in non-exposed individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Population attributable risk:&nbsp;</strong>Is a measure of the Incidence of the disease that is likely to be reduced if the risk factor is modified/eliminated.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-173900_fDr5Jo4.jpg\" alt=\"\" width=\"769\" height=\"62\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Odds ratio:&nbsp;</strong>Is a measure of the odds of exposure among cases compared to the odds of exposure among controls in a case-control study.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Attributable risk is the metric that indicates the difference in the incidence of disease between exposed and non-exposed groups, representing the proportion of disease occurrence attributable to the exposure.</span></p>",
    "correct_choice_id": 40831,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10202,
    "choices": [
      {
        "id": 40774,
        "text": "<p><span style=\"font-size:12.0pt;\">Yellow</span></p>"
      },
      {
        "id": 40775,
        "text": "<p><span style=\"font-size:12.0pt;\">White</span></p>"
      },
      {
        "id": 40776,
        "text": "<p><span style=\"font-size:12.0pt;\">Red</span></p>"
      },
      {
        "id": 40777,
        "text": "<p><span style=\"font-size:12.0pt;\">Green</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Where chemical waste can be disposed? (NEET PG 2020)</span></p>",
    "unique_key": "Q1050325",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305535,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Yellow</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chemical waste is disposed of in yellow-colored containers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-150042.png\" alt=\"\" width=\"1000\" height=\"1277\"></p>",
    "correct_choice_id": 40774,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11056,
    "choices": [
      {
        "id": 44190,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">e-VIN</span></p>"
      },
      {
        "id": 44191,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Freeze indicator</span></p>"
      },
      {
        "id": 44192,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Vaccine vial monitor</span></p>"
      },
      {
        "id": 44193,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Fridge indicator</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">You are overseeing the arrival of vaccines at a remote clinic. To ensure the vaccines have maintained their potency during transit, which tool would you use? </span><span style=\"color:black;font-size:12.0pt;\">(AIIMS MAY 2018)</span></p>",
    "unique_key": "Q9599673",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305492,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. C) Vaccine vial monitor</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Vaccine vial monitors (VVM) are heat-sensitive indicators routinely used to monitor heat exposure of the vaccine and determine vaccine viability as the vaccine vial moves across the supply chain.</span></li><li><span style=\"color:black;font-size:12.0pt;\">VVMs change color as the vaccine is exposed to cumulative heat. If the color of inner square is similar or darker than the outer circle, the vaccine vial should be discarded.</span></li><li><span style=\"color:black;font-size:12.0pt;\">A VVM can be used to assess vaccine potency and not vaccine efficacy.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Expiry date can\u2019t be determined by VVM and has no relation to extend the expiry date.</span></li><li><span style=\"color:black;font-size:12.0pt;\">If the square and the circle are the same in colour or square is darker, then the vaccine should be discarded.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture52222.jpg\" alt=\"\" width=\"700\" height=\"370\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. e-VIN:&nbsp;</strong>e-VIN (Electronic Vaccine Intelligence Network) tracks the stock status and temperature of vaccine inventories via the internet, but it does not assess the viability of individual vaccine vials upon arrival.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Freeze indicator:</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\">Freeze indicator detects exposure to freezing temperatures, which can damage vaccines, but it does not indicate heat exposure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>Fridge indicator:&nbsp;</strong>Fridge indicator monitors the temperature inside a refrigerator, ensuring it remains within a safe range but does not provide specific information about the exposure of individual vaccine vials during transport.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture422.jpg\" alt=\"\" width=\"800\" height=\"580\"></span></p>",
    "correct_choice_id": 44192,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "InstrumentsBased"
    ]
  },
  {
    "id": 57609,
    "choices": [
      {
        "id": 229805,
        "text": "<p><span style=\"font-size:12.0pt;\">Monthly IFA supplementations</span></p>"
      },
      {
        "id": 229806,
        "text": "<p><span style=\"font-size:12.0pt;\">Sanitary napkins distribution</span></p>"
      },
      {
        "id": 229807,
        "text": "<p><span style=\"font-size:12.0pt;\">Albendazole for deworming</span></p>"
      },
      {
        "id": 229808,
        "text": "<p><span style=\"font-size:12.0pt;\">Health check-ups</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a component of School Health under Ayushman Bharat Program? (NEET PG 2024)</span></p>",
    "unique_key": "Q3711075",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305548,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Monthly IFA supplementations</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Ayushman Bharat Program includes a comprehensive school health component aimed at improving the health and hygiene of school children. The key components include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Weekly Iron Folic Acid Supplementation (WIFS):</strong> This involves the distribution of iron and folic acid supplements on a weekly basis to prevent anemia among school children. Monthly supplementation is not part of this program; hence, \"Monthly IFA supplementations\" is the incorrect option.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Sanitary Napkins Distribution:</strong> Under the menstrual hygiene scheme, sanitary napkins branded as \"Freedays\" are distributed to adolescent girls to promote menstrual hygiene.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Albendazole for Deworming:</strong> Deworming through albendazole is conducted to reduce the prevalence of intestinal worm infestations among school-aged children.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Health Check-ups:</strong> Regular health screenings are conducted to assess the physical and mental fitness of students, ensuring early identification and management of health issues.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Ayushman Bharat School Health Program includes weekly IFA supplementation, not monthly, along with other health initiatives like menstrual hygiene, deworming, screening health check-ups, physical &amp; mental fitness, Research and Vaccination</span></p>",
    "correct_choice_id": 229805,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 11057,
    "choices": [
      {
        "id": 44194,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Panchayat Health Committee</span></p>"
      },
      {
        "id": 44195,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Village Health Planning and Management Committee</span></p>"
      },
      {
        "id": 44196,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Rogi Kalyan Samiti</span></p>"
      },
      {
        "id": 44197,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Village Health Sanitation and Nutrition Committee</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">As part of a health development project in rural India, you're asked about the key community group responsible for overseeing local health, sanitation, and nutrition initiatives. Which committee best fits this description? </span><span style=\"color:black;font-size:12.0pt;\">(AIIMS MAY 2018)</span></p>",
    "unique_key": "Q8654524",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305493,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) Village Health Sanitation and Nutrition Committee</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">One of the key elements of the National Rural Health Mission is the Village Health, Sanitation and Nutrition committee (VHSNC).</span></li><li><span style=\"color:black;font-size:12.0pt;\">The committee has been formed to take collective actions on issues related to health and its social determinants at the village level.</span></li><li><span style=\"color:black;font-size:12.0pt;\">They are particularly envisaged as being central to \u2018local level community action\u2019 under NRHM, which would develop to support the process of Decentralized Health Planning.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Thus VHSNC is envisaged to take leadership in providing a platform for improving health awareness and access of community for health services, address specific local needs and serve as a mechanism for community based planning and monitoring.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The committee is formed at the revenue village level and it should act as a sub-committee of the Gram Panchayat.</span></li><li><span style=\"color:black;font-size:12.0pt;\">It should have a minimum of 15 members which should comprise of elected member of the Panchayat who shall lead the committee, all those working for health and health related services should participate, community members/ beneficiaries and representation from all community sub-groups especially the vulnerable sections and hamlets/ habitations. ASHA residing in the village shall be the member secretary and convener of the committee.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">&nbsp;<strong>ROLES AND RESPONSIBILITIES&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Create awareness about nutritional issues and significance of nutrition as an important determinant of health.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Carry out survey on nutritional status and nutritional deficiencies in the village especially among women and children.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Identify locally available food stuffs of high nutrient value as well as disseminate and promote best practices (traditional wisdom) congruent with local culture, capabilities and physical environment through a process of community consultation.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Inclusion of Nutritional needs in the Village Health Plan \u2013 The committee will do an in-depth analysis of causes of malnutrition at the community and household levels, by involving the ANM, AWW, ASHA and ICDS Supervisors.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Monitoring and Supervision of Village Health and Nutrition Day to ensure that it is organized every month in the village with the active participation of the whole village.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Facilitate early detection of malnourished children in the community; tie up referral to the nearest Nutritional Rehabilitation Centre (NRC) as well as follow up for sustained outcome.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Supervise the functioning of Anganwadi Centre (AWC) in the village and facilitate its working in improving nutritional status of women and children.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Act as a grievances redressal forum on health and nutrition issues.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Panchayat Health Committee&nbsp;</strong>and <strong>Option B. Village Health Planning and Management Committee&nbsp;</strong>generally refer to broader terms, but they do not specifically target the integrated approach of the VHSNC.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option C. Rogi Kalyan Samiti (Patient Welfare Committee) / Hospital Management Committee&nbsp;</strong>is a simple yet effective management structure. This committee, a registered society, acts as a group of trustees for the hospitals to manage the affairs of the hospital. It consists of members from local Panchayati Raj Institutions (PRIs), NGOs, local elected representatives and officials from Government sector who are responsible for proper functioning and management of the hospital / Community Health Centre / FRUs. RKS / HMS is free to prescribe, generate and use the funds with it as per its best judgement for smooth functioning and maintaining the quality of services.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The VHSNC plays a crucial role in the grassroots-level health planning and implementation in rural India, ensuring that health initiatives are tailored to the specific needs and conditions of the community.</span></li><li><span style=\"font-size:12pt;\">It is a vital part of the health ecosystem, facilitating a comprehensive approach to public health management in rural settings.</span></li></ul>",
    "correct_choice_id": 44197,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11071,
    "choices": [
      {
        "id": 44250,
        "text": "<p><span style=\"font-size:12.0pt;\">Strength of correlation is same in A and B</span></p>"
      },
      {
        "id": 44251,
        "text": "<p><span style=\"font-size:12.0pt;\">Strength of the correlation is more in A than in B</span></p>"
      },
      {
        "id": 44252,
        "text": "<p><span style=\"font-size:12.0pt;\">Strength of the variation is more in B than A</span></p>"
      },
      {
        "id": 44253,
        "text": "<p><span style=\"font-size:12.0pt;\">Variation in variables is more with A than B</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A perinatologist is analyzing scatterplots from two research studies on the relationship between bone marrow density and gestational age. Study A shows data points tightly clustered along a trend line, while Study B shows data points that are more spread out but still follow a general trend line. Which statement correctly describes the relationship between bone marrow density and gestational age based on these observations? (AIIMS MAY 2019)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip12.jpg\" alt=\"\" width=\"200\" height=\"450\"></span></p>",
    "unique_key": "Q9684976",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305507,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Strength of the correlation is more in A than in B</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Graph A represents stronger correlation than graph B.</span></li><li><span style=\"font-size:12.0pt;\">More compact and close the dots are to the line, stronger is the relation.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/picture11_Zx8B4xH.jpg\" alt=\"\" width=\"700\" height=\"254\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/screenshot-2023-10-23-124648.jpg\" alt=\"\" width=\"1000\" height=\"664\"></p>",
    "correct_choice_id": 44251,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "ImageBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 11058,
    "choices": [
      {
        "id": 44198,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">50</span></p>"
      },
      {
        "id": 44199,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">100</span></p>"
      },
      {
        "id": 44200,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">150</span></p>"
      },
      {
        "id": 44201,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">200</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">While working at a rural health sub-centre, you and a medical intern are analyzing annual infant registration metrics. The intern inquires about the expected annual infant registration rate when a health worker is actively on duty at the sub center. What is the best representation of this rate? </span><span style=\"color:black;font-size:12.0pt;\">(AIIMS MAY 2018)</span></p>",
    "unique_key": "Q3961896",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305494,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. C) 150</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Each year, a total of 150 infants should be enrolled at a sub-centre.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Annual infant population = Total population \u00d7 % infants in population or expected birth rate</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">The infant population percentage, or the anticipated birth rate, ought to be derived from local data. In cases where a specific local percentage is not accessible, it is approximated at 3% of the overall population.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Total population in a sub centre = 5000.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Here, annual infant population = 5000 \u00d7 3/100 = 150</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Total population catered by a Sub centre = 5000</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Crude birth rate (CBR) India = 19 per 1000 Mid-year population (SRS 2016)</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">So, estimated number of births in a year = 19/1000 \u00d75000 = 95 births per year</span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Also, current Infant mortality rate (IMR) India = 28 per 1000 Live births</span></li><li><span style=\"color:black;font-size:12.0pt;\">So, Expected number of infant deaths in a year in that population = 28/1000 \u00d7 95 = 2.7 deaths</span></li><li><span style=\"color:black;font-size:12.0pt;\">So, total number of expected alive infants = 95 \u2013 2.7 = 92 Infants approximately</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In a rural health sub-centre, the expected annual infant registration rate effectively captures both the births and adjustments for infant mortality.</span></li><li><span style=\"font-size:12.0pt;\">The number 150 serves as a practical target for ensuring all newborns are accounted for within the community health system.</span></li><li><span style=\"font-size:12.0pt;\">This figure supports proactive health planning and resource allocation, emphasizing the importance of accurate and timely health data registration.</span></li></ul>",
    "correct_choice_id": 44200,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11065,
    "choices": [
      {
        "id": 44226,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">From onset of rash to 3 days after rash</span></p>"
      },
      {
        "id": 44227,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">2 weeks before rash to 1 week after rash</span></p>"
      },
      {
        "id": 44228,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">From onset of rash to 5 days after rash</span></p>"
      },
      {
        "id": 44229,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">From catarrhal stage to 4 days after rash</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">In a busy OPD at a District hospital, you are evaluating a 5-year-old boy who presents with fever, generalized malaise, and a distinctive rash. The child's clinical presentation strongly suggests a diagnosis of measles. The mother, anxious about the contagious nature of the disease and the risk it poses to her other kids and family members, inquires about the recommended period of isolation for her infected child. What would be your most appropriate recommendation for the duration of isolation? (AIIMS MAY 2018)</span></p>",
    "unique_key": "Q1184377",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305501,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) From catarrhal stage to 4 days after rash</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Patient should be advised to stay in isolation from onset of catarrhal stage to 3rd/4th day of rash.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Isolation is the separation for the period of communicability, of infected persons from others in such places/conditions as to prevent/limit transmission to those susceptible.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/disease.jpg\" alt=\"\" width=\"600\" height=\"764\"></span></p>",
    "correct_choice_id": 44229,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 10222,
    "choices": [
      {
        "id": 40854,
        "text": "<p><span style=\"font-size:12.0pt;\">H1N1</span></p>"
      },
      {
        "id": 40855,
        "text": "<p><span style=\"font-size:12.0pt;\">H5N1</span></p>"
      },
      {
        "id": 40856,
        "text": "<p><span style=\"font-size:12.0pt;\">H5N7</span></p>"
      },
      {
        "id": 40857,
        "text": "<p><span style=\"font-size:12.0pt;\">H3N2</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which influenza virus was responsible for the 2009 pandemic? (NEET PG 2020)</span></p>",
    "unique_key": "Q7430246",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305520,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) H1N1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The 2009 influenza pandemic, commonly referred to as the \"swine flu\" pandemic, was caused by the H1N1 influenza A virus. This virus emerged in Mexico and quickly spread worldwide, causing widespread illness and leading to a global pandemic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;<strong>H5N1:&nbsp;</strong>Known as the \"bird flu\" virus.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Year:&nbsp;</strong>First identified in 1997 in Hong Kong.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Impact:&nbsp;</strong>Primarily affects birds but can infect humans, causing severe respiratory illness.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;<strong>H5N7:&nbsp;</strong>This subtype of influenza is not known to have caused any major pandemics or widespread outbreaks in humans.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>H3N2:&nbsp;</strong>This subtype of influenza A virus is known to cause seasonal flu epidemics but was not responsible for the 2009 pandemic.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Year:&nbsp;</strong>H3N2 was involved in the 1968 influenza pandemic, known as the \"Hong Kong flu.\"</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Influenza Pandemics</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">SWINE FLU, H1N1 \u2192 2009, Mexico</span></p><p><span style=\"font-size:12.0pt;\">BIRD FLU, H7N9 \u2192 2013, China</span></p><p><span style=\"font-size:12.0pt;\">BIRD FLU, H5N1 \u2192 1997, Hong Kong</span></p><p><span style=\"font-size:12.0pt;\">BIRD FLU, H10N3 \u2192 2021, China</span></p>",
    "correct_choice_id": 40854,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10251,
    "choices": [
      {
        "id": 40970,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
      },
      {
        "id": 40971,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
      },
      {
        "id": 40972,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
      },
      {
        "id": 40973,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">You are employed at a primary health center (PHC) located in an area with a high risk of earthquakes. What actions would you take to ensure readiness for potential emergencies? (NEET PG 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Disaster preparedness by making sure all financial and other resources are available</span></li><li><span style=\"font-size:12.0pt;\">Increase public awareness through campaigns and loudspeakers</span></li><li><span style=\"font-size:12.0pt;\">Conduct a simulation for the disaster and assess the response</span></li><li><span style=\"font-size:12.0pt;\">Follow instructions given over the phone or radio by higher officials</span></li></ol>",
    "unique_key": "Q3462093",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305537,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1,2,3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">To ensure readiness for potential emergencies in a high-risk earthquake area, the following actions are crucial:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Disaster Preparedness:</strong> Ensuring all financial and other resources are available. This involves mobilizing funds and resources for quick evacuation and emergency response.</span></li><li><span style=\"font-size:12pt;\"><strong>Increase Public Awareness:</strong> Conducting campaigns and using loudspeakers to inform the public about earthquake preparedness measures and safety protocols.</span></li><li><span style=\"font-size:12pt;\"><strong>Conduct a Simulation:</strong> Performing disaster simulations and assessing the response to identify areas for improvement and ensure the effectiveness of the emergency plan.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">These steps are essential components of a comprehensive disaster preparedness strategy and done by someone working in a PHC situated in a high seismic zone. A medical officer is supposed to provide instructions by any communication method possible to manage through the calamity.</span></p><p>&nbsp;</p><h3><span style=\"color:black;font-size:12pt;\"><strong>Roles and responsibilities of medical officer of PHC when posted in Seismic areas</strong></span></h3><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Ensure funds and resources are available and can be mobilized at the time of disaster for quick evacuation</span></li><li><span style=\"font-size:12.0pt;\">Preparedness to handle emergency</span></li><li><span style=\"font-size:12.0pt;\">Disaster simulation practices and then check the response</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">While following instructions from higher officials is important during an actual disaster, it is not a proactive preparedness measure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Emergency preparedness is a programme of long-term development activities whose goals are to strengthen the overall capacity and capability of a country to manage efficiently all types of emergency. It involves the following steps:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Disaster preparedness by making sure all financial and other resources are available</span></li><li><span style=\"font-size:12.0pt;\">Increase public awareness through campaigns and loudspeakers</span></li><li><span style=\"font-size:12.0pt;\">Conduct a simulation for the disaster and assess the response</span></li><li><span style=\"font-size:12.0pt;\">Evaluate the risk of disaster</span></li><li><span style=\"font-size:12.0pt;\">Information sessions coordination with news media</span></li><li><span style=\"font-size:12.0pt;\">Adopt standards and regulations</span></li></ol>",
    "correct_choice_id": 40972,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10219,
    "choices": [
      {
        "id": 40842,
        "text": "<p><span style=\"font-size:12.0pt;\">Full course of tetanus vaccination</span></p>"
      },
      {
        "id": 40843,
        "text": "<p><span style=\"font-size:12.0pt;\">Single dose tetanus toxoid</span></p>"
      },
      {
        "id": 40844,
        "text": "<p><span style=\"font-size:12.0pt;\">Tetanus</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">toxoid</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">+</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">immunoglobulin</span></p>"
      },
      {
        "id": 40845,
        "text": "<p><span style=\"font-size:12.0pt;\">No vaccination needed</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient arrives with a clean-cut injury, no lacerations. He reports receiving his last tetanus vaccination approximately a decade ago. What would be the recommended course of action? (NEET PG 2020)</span></p>",
    "unique_key": "Q9316361",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305522,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Single dose tetanus toxoid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The recommended course of action for a patient with a clean-cut injury who received their last tetanus vaccination approximately a decade ago is to administer a single dose of tetanus toxoid. This recommendation is based on the standard guidelines for tetanus prophylaxis in wound management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p style=\"text-align:center;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-173902.jpg\" alt=\"\" width=\"800\" height=\"380\"></span></p>",
    "correct_choice_id": 40843,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "RecentNEETPG",
      "TreatmentBased"
    ]
  },
  {
    "id": 10209,
    "choices": [
      {
        "id": 40802,
        "text": "<p><span style=\"font-size:12.0pt;\">Coefficient of correlation</span></p>"
      },
      {
        "id": 40803,
        "text": "<p><span style=\"font-size:12.0pt;\">Coefficient of Regression</span></p>"
      },
      {
        "id": 40804,
        "text": "<p><span style=\"font-size:12.0pt;\">Coefficient of variation</span></p>"
      },
      {
        "id": 40805,
        "text": "<p><span style=\"font-size:12.0pt;\">Coefficient of determination</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following calculates one variable using another variable? (NEET PG 2020)</span></p>",
    "unique_key": "Q8895469",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305529,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Coefficient of Regression</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Coefficient of Regression can be used to calculate one variable using another variable.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Coefficient of Regression is a statistical measure that assesses the strength and direction of the relationship between two variables. It is used to predict or estimate the value of one variable based on the value of another variable.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For example, in a regression analysis, we may want to predict a person's weight based on their height. In this case, height would be the independent variable and weight would be the dependent variable. The coefficient of regression would help us determine the relationship between these variables and enable us to make predictions about a person's weight based on their height.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;The Coefficient of Correlation:&nbsp;</strong> Measures the strength and direction of the linear relationship between two variables.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. &nbsp;The Coefficient of Variation</strong>: Is a measure of the relative variability of a dataset.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;The Coefficient of Determination: </strong>Is a measure that determines the proportion of the variance in the dependent variable that is explained by the independent variable in a regression analysis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Coefficient of Regression is used to calculate or predict the value of one variable based on the value of another variable, quantifying the relationship between the independent and dependent variables in regression analysis.</span></p>",
    "correct_choice_id": 40803,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11070,
    "choices": [
      {
        "id": 44246,
        "text": "<p><span style=\"font-size:12.0pt;\">Chi square</span></p>"
      },
      {
        "id": 44247,
        "text": "<p><span style=\"font-size:12.0pt;\">Paired t test</span></p>"
      },
      {
        "id": 44248,
        "text": "<p><span style=\"font-size:12.0pt;\">Wilcoxan test</span></p>"
      },
      {
        "id": 44249,
        "text": "<p><span style=\"font-size:12.0pt;\">ANOVA</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A public health researcher is studying the prevalence of a disease among school-aged children in a suburban town across two separate periods during the monsoon season. Two unpaired cohorts of children are observed: one from June to July and another from August to September. To compare the prevalence rates between these two cohorts, which statistical test is most appropriate? (AIIMS MAY 2019)</span></p>",
    "unique_key": "Q6366991",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305506,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Chi square</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Chi-square test can be implemented in this given scenario.</span></li><li><span style=\"font-size:12.0pt;\">The data is expressed as proportion of children affected by the disease in various months.</span></li><li><span style=\"font-size:12.0pt;\">It is a qualitative variable as we assess the proportion of children who are affected by the disease and those who are not affected by the disease. The chi-square test can be used to compare two or more groups.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Chi square:</strong> Non parametric test used for comparing percentage, proportions &amp; fractions in two or more different group of individuals.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Example: Three-fourth of MBBS students in a class are underweight whereas another class has two thirds anaemic; test of significance to be used is Chi-square test</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fischer\u2019s test: Is a variant of Chi-square test when sample size is &lt; 30</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Paired t test:&nbsp;</strong>Parametric test which is used to compare means (+ SD) in paired data (in same group of individuals before and after an intervention)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Example: Mean serum albumin level of dengue patients before treatment was 3.6 g/dL and after treatment was 3.2 g/dL; Comparison of mean levels can be done by Paired Student\u2019s t-test (<strong>Unpaired Student\u2019s t-test </strong>is for comparing means (+ SD) in two different group of individuals - Example: Mean Hb level of anemia patients was 9.6 g/dL and those of hookworm patients was 7.2 g/dL; Comparison of mean levels can be done by Unpaired Student\u2019s t-test; Z - test: Is a variant of student\u2019s t-test which is used when sample size is &gt; 30)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Wilcoxon test:</strong> Non parametric test used for comparing percentage, proportions &amp; fractions in matched paired data</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Wilcoxon (rank sum) test: Comparing percentage, proportions &amp; fractions in two unpaired samples</span></li><li><span style=\"font-size:12.0pt;\">Mann-Whitney (Wilcoxon) test:</span><ul><li><span style=\"font-size:12.0pt;\">MWW is same as Wilcoxon (rank sum) test</span></li><li><span style=\"font-size:12.0pt;\">Is used for assessing whether two set of observations come from same distribution (if 2 independent \u2018nonpaired\u2019 samples come from the same population)</span></li><li><span style=\"font-size:12.0pt;\">\u2018MWW is analogous to parametric two-sample t-test\u2019 on the data after ranking over the combined samples</span></li><li><span style=\"font-size:12.0pt;\">MWW requires calculation of \u2018U statistic\u2019.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. ANOVA (Analysis of Variance) (F-test/F-ratio)</strong>: Parametric test used to compare means (+ SD) in more than two different group of individuals</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Example: Mean weight of students in class A is 50 kg, those of class B is 44.6 kg&nbsp;and those of class C is 52.7 kg; Comparison of mean weights can be done by&nbsp;ANOVA test.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/picture9.jpg\" alt=\"\" width=\"700\" height=\"377\"></span></p>",
    "correct_choice_id": 44246,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 11072,
    "choices": [
      {
        "id": 44254,
        "text": "<p><span style=\"font-size:12.0pt;\">If 1, 2, and 3 are correct</span></p>"
      },
      {
        "id": 44255,
        "text": "<p><span style=\"font-size:12.0pt;\">If 1 and 3 are correct</span></p>"
      },
      {
        "id": 44256,
        "text": "<p><span style=\"font-size:12.0pt;\">If 2 and 4 are correct</span></p>"
      },
      {
        "id": 44257,
        "text": "<p><span style=\"font-size:12.0pt;\">If all (1,2,3 &amp; 4) are correct</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A team of researchers is conducting investigations to evaluate the impact of interventions targeting a specific disease. Two independent studies, labeled as A and B, are analyzed. Study A utilized an intervention denoted as \"X\", and Study B utilized an intervention denoted as \"Y\". Both studies incorporate control groups. The calculated p-values for studies A and B, with 95% confidence intervals, were found to be 0.02 and 0.001, respectively.&nbsp; Based on this information, which of the following conclusions is most appropriate? (AIIMS MAY 2019)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Study B is more precise than study A and intervention Y is more significant compared to Intervention X.</span></li><li><span style=\"font-size:12.0pt;\">Study A is more precise than study B and intervention X is more significant compared to Intervention Y.</span></li><li><span style=\"font-size:12.0pt;\">Both X and Y show a significant variation, but Study B is more significant than Study A.</span></li><li><span style=\"font-size:12.0pt;\">Both study A and B show a significant variation and both interventions have similar statistical significance.</span></li></ol>",
    "unique_key": "Q3138505",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305508,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) If 1 and 3 are correct</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Statements 1 and 3 are accurate. The p-value for study A involving intervention X within a 95% confidence interval stands at 0.02.</span></li><li><span style=\"font-size:12.0pt;\">In the case of study B, employing intervention Y within the same confidence interval, the p-value is 0.001.</span></li><li><span style=\"font-size:12.0pt;\">Both studies' probability (p) values fall below the 0.05 threshold (level of significance - \u03b1), leading to the conclusion that both studies A and B hold significance and thus warrant the rejection of the null hypothesis.</span></li><li><span style=\"font-size:12.0pt;\">Nevertheless, study B exhibits a p-value lower than that of study A, implying that the precision and significance of study B, involving intervention Y, surpass those of study A with intervention X.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option 2:</strong> This is incorrect as it mistakenly asserts that Study A, which had a higher p-value, would be more precise and that intervention X would be more significant than intervention Y. This is opposite to what the p-values suggest.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option 4:</strong> Also incorrect because it suggests that both interventions have similar statistical significance, which contradicts the considerable difference in their p-values. A lower p-value in Study B indicates a stronger statistical significance compared to Study A.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In interpreting clinical study results, a lower p-value indicates stronger evidence against the null hypothesis and typically points to a more significant intervention effect.</span></li><li><span style=\"font-size:12.0pt;\">In this scenario, Study B's intervention (Y) is statistically more significant than Study A's intervention (X), indicating a potentially more effective or impactful intervention.</span></li></ul>",
    "correct_choice_id": 44255,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 11041,
    "choices": [
      {
        "id": 44130,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">60</span></p>"
      },
      {
        "id": 44131,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">80</span></p>"
      },
      {
        "id": 44132,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">100</span></p>"
      },
      {
        "id": 44133,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">110</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dr. Radhika, the district health officer, is evaluating the efficiency of a subcenter in a rural region of India. This subcenter services a population of 5,000 people, and it has been reported that the crude birth rate (CBR) in this region stands at 20 per 1,000 people. Dr. Radhika wants to ensure that every pregnant woman receives antenatal care (ANC) to promote healthy pregnancies and reduce complications. With the current CBR, how many ANC registrations should the village health nurse (VHN) expect to handle annually? (AIIMS MAY 2017)</span></p>",
    "unique_key": "Q9523913",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305483,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. A) 60</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Calculation&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">A subcentre serves a population of 5000 in plains.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">CBR given is 20.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Expected number of pregnancies can be calculated by: Birth rate x population of the area / 1000 = 20 \u00d7 5000/1000 = 100.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">A correction factor of 10% is added to adjust for pregnancy wastage in the form of abortions or stillbirths.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Hence, total number of expected pregnancies = Expected number of pregnancies + 10% of the same&nbsp;= 100 + 10&nbsp;= 110</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">&nbsp;Since not all pregnancies are officially registered, an Auxiliary Nurse Midwife (ANM) is typically expected to have at least half of the anticipated pregnancies under her care registered at any point in time. Therefore, the count of Antenatal Care (ANC) registrations is calculated as 50% of the projected pregnancies.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Therefore, Total ANC registrations expected = total number of expected pregnancies/2 = 55</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">The closest answer is 60.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In assessing ANC needs based on CBR in a rural health setting, it's crucial to accurately apply demographic statistics to the actual population size.</span></li><li><span style=\"font-size:12.0pt;\">Expectations should align with direct calculations unless specific adjustments are warranted by local conditions or policies.</span></li></ul>",
    "correct_choice_id": 44130,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 11082,
    "choices": [
      {
        "id": 44294,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tuberculosis</span></span></span></p>"
      },
      {
        "id": 44295,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Herpes Zoster</span></span></span></p>"
      },
      {
        "id": 44296,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Measles</span></span></span></p>"
      },
      {
        "id": 44297,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chicken Pox</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 40-year-old nurse in the infectious diseases ward is reviewing the necessary precautions for attending to patients with various primary diagnoses. For which of the following patients would she NOT need to take special airborne precautions? (AIIMS MAY 2020)</span></span></span></p>",
    "unique_key": "Q2537977",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305518,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Herpes Zoster&nbsp;</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While Herpes Zoster (shingles) can be contagious, it primarily requires contact precautions unless disseminated or in the immunocompromised, where it might necessitate airborne precautions if there are pulmonary symptoms. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Generally, for localized shingles in an immunocompetent patient, standard precautions along with contact precautions are sufficient, thus not routinely requiring airborne precautions like the diseases listed in the other options.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Tuberculosis:</span></strong><span style=\"font-size:12.0pt\"> Requires airborne precautions due to the high risk of transmission through airborne particles, particularly the respiratory droplets that can suspend in the air for extended periods.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Measles:</span></strong><span style=\"font-size:12.0pt\"> Highly contagious and spreads through airborne transmission. Airborne precautions are essential due to measles&#39; ability to remain airborne for up to two hours after the infected person has left the area.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Chicken Pox (Varicella):</span></strong><span style=\"font-size:12.0pt\"> Also spread through airborne transmission, requiring similar precautions to measles to prevent the spread of the virus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Measles, Tuberculosis, and chickenpox require airborne transmission precaution unlike herpes zoster.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient should be made to wear a mask for source control. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A fit-tested NIOSH-approved N95 or higher-level respirator should be used by the healthcare personnel whilst care delivery.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 44295,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "Factual"
    ]
  },
  {
    "id": 10256,
    "choices": [
      {
        "id": 40990,
        "text": "<p><span style=\"font-size:12.0pt;\">Caters to a population of 1-1.5 lakh</span></p>"
      },
      {
        "id": 40991,
        "text": "<p><span style=\"font-size:12.0pt;\">Referral centre for 2- 3 primary health centers</span></p>"
      },
      {
        "id": 40992,
        "text": "<p><span style=\"font-size:12.0pt;\">No sub-district and district hospitals present in the area</span></p>"
      },
      {
        "id": 40993,
        "text": "<p><span style=\"font-size:12.0pt;\">Should have a 100-bed facility in metro cities&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which statement most accurately refers to the requirements for initiating an urban community health center? (NEET PG 2022)</span></p>",
    "unique_key": "Q8847803",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305542,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Should have a 100-bed facility in metro cities&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>U-CHC (URBAN - COMMUNITY HEALTH CENTRE)</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An Urban Community Health Center (U-CHC) is designed to provide inpatient care and other health services in urban areas. According to the IPHS 2022 Guidelines, the requirements for U-CHCs are as follows:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">30-50 bedded U-CHC providing inpatient care in cities (&gt;1 per 500,000 population)</span></li><li><span style=\"font-size:12.0pt;\">75-100 bedded U-CHC facilities in metros</span></li><li><span style=\"font-size:12.0pt;\">U-CHC may be set up as a satellite hospital for every 4-5 U-PHCs</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-103851.png\" alt=\"\" width=\"1000\" height=\"633\"></p>",
    "correct_choice_id": 40993,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11034,
    "choices": [
      {
        "id": 44102,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">300-400</span></p>"
      },
      {
        "id": 44103,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">200-300</span></p>"
      },
      {
        "id": 44104,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Below 250</span></p>"
      },
      {
        "id": 44105,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Above 350</span></p>"
      }
    ],
    "text": "<p style=\"margin-left:-9px;\"><span style=\"color:black;font-size:12.0pt;\">An esteemed research institute recently conducted a comprehensive study on individuals diagnosed with HIV to understand the progression and current health status of the participants. As a part of this study, the CD4 count, which plays a critical role in assessing the immune status of these individuals, was meticulously measured. Given the graphical representation provided that depicts the distribution of CD4 counts, can you infer the average CD4 count range that can be derived from this graph?&nbsp;(AIIMS MAY 2017)</span></p><p>&nbsp;</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip2.jpg\" alt=\"\" width=\"300\" height=\"253\"></p>",
    "unique_key": "Q7223811",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305478,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. A) 300-400</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">If we convert the given graph data into a table, it will be as follows:</span></p><p><br><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/screenshot-2023-10-18-113657_rVUMCJ4.jpg\" alt=\"\" width=\"778\" height=\"589\"></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">To determine the midpoint of each provided interval, it is necessary to calculate the midpoint for each interval individually. Following this, the resulting midpoints should be multiplied by the corresponding interval frequencies.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Mean = Sum of all observations / number of observations.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/screenshot-2023-10-18-114014.jpg\" alt=\"\" width=\"800\" height=\"445\"></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Mean = 34500/100 = 345.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">Hence, 300 -400 is the answer.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">When interpreting a frequency distribution graph like this for CD4 counts in HIV-positive individuals, it's essential to compute the weighted average based on the midpoint of each interval and the frequency of observations within each interval.</span></li><li><span style=\"font-size:12.0pt;\">This provides a more accurate assessment of the overall average CD4 count, crucial for understanding the immune status in a clinical setting.</span></li></ul>",
    "correct_choice_id": 44102,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "ImageBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 10259,
    "choices": [
      {
        "id": 41002,
        "text": "<p><span style=\"font-size:12.0pt;\">CARE</span></p>"
      },
      {
        "id": 41003,
        "text": "<p><span style=\"font-size:12.0pt;\">UNDP</span></p>"
      },
      {
        "id": 41004,
        "text": "<p><span style=\"font-size:12.0pt;\">UNICEF</span></p>"
      },
      {
        "id": 41005,
        "text": "<p><span style=\"font-size:12.0pt;\">WHO</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which agency offers seeds and manure as part of applied nutrition programs in schools? (NEET PG 2022)</span></p>",
    "unique_key": "Q8105283",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305545,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) UNICEF</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>UNICEF</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Applied Nutrition Program</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">UNICEF promoted the scheme by supplying basic equipment for production and training while FAO and WHO were involved in providing technical advice</span></li><li><span style=\"font-size:12.0pt;\">UNICEF provided seeds, manure and water supply equipment for developing School gardens, to be utilized in school feeding programs</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/04/screenshot-2023-10-04-123627.jpg\" alt=\"\" width=\"400\" height=\"348\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. CARE: &nbsp;</strong>- \u2018Cooperative for Assistance and Relief Everywhere\u2019 supports following project:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Integrated Nutrition and Health Project</span></li><li><span style=\"font-size:12.0pt;\">Better Health and Nutrition Project</span></li><li><span style=\"font-size:12.0pt;\">Anaemia Control Project</span></li><li><span style=\"font-size:12.0pt;\">Improving Women's Health Project</span></li><li><span style=\"font-size:12.0pt;\">Improved Health Care for Adolescent Girl's Project</span></li><li><span style=\"font-size:12.0pt;\">Child Survival Project</span></li><li><span style=\"font-size:12.0pt;\">Improving Women's Reproductive Health and Family Spacing Project</span></li><li><span style=\"font-size:12.0pt;\">Konkan Integrate Development Project</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. UNDP:&nbsp;</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">The basic objective of the UNDP is to help poorer nations develop their human and natural resources more fully. The UNDP projects cover virtually every economic and social sector - agriculture, industry, education and science, health, social welfare, etc.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. WHO:&nbsp;</strong> World Health Organization aims at the attainment of the highest level of health by all people, which helps them to lead a socially and economically productive life.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-124958.png\" alt=\"\" width=\"400\" height=\"298\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">UNICEF provides seeds, manure, and water supply equipment as part of its Applied Nutrition Program to develop school gardens, which are used in school feeding programs to improve children's nutrition.</span></p>",
    "correct_choice_id": 41004,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10221,
    "choices": [
      {
        "id": 40850,
        "text": "<p><span style=\"font-size:12.0pt;\">Variance</span></p>"
      },
      {
        "id": 40851,
        "text": "<p><span style=\"font-size:12.0pt;\">Coefficient of variation</span></p>"
      },
      {
        "id": 40852,
        "text": "<p><span style=\"font-size:12.0pt;\">Standard error of mean</span></p>"
      },
      {
        "id": 40853,
        "text": "<p><span style=\"font-size:12.0pt;\">Standard</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">deviation</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A comparison is made between the variability present in one dataset and that in another dataset by: (NEET PG 2020)</span></p>",
    "unique_key": "Q4967060",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305521,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Coefficient of variation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Coefficient of Variation (CV) is used to compare the relative variability of different datasets. It is a standardized measure of dispersion of a probability distribution or frequency distribution. The CV is particularly useful because it expresses the standard deviation as a percentage of the mean, making it possible to compare the degree of variation from one dataset to another, regardless of the unit of measurement or magnitude of the mean.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Co-efficient of Variation [COV] = SD/Mean x 100</span></li><li><span style=\"font-size:12.0pt;\">It measures the relative variability by using the mean and standard deviation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;<strong>Variance:&nbsp;</strong>Variance measures the spread of a set of numbers. It is the average of the squared differences from the mean. While it indicates variability, it does not provide a standardized measure for comparison between different datasets.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;<strong>Standard Error of Mean (SEM):&nbsp;</strong>The SEM measures how much the sample mean of the data is likely to vary from the true population mean. It is used to understand the accuracy of the sample mean but is not used for comparing variability between datasets.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>Standard Deviation (SD):&nbsp;</strong>Standard deviation is a measure of the amount of variation or dispersion in a set of values. While it indicates the spread of data points, it does not standardize this measure in relation to the mean, which is necessary for comparing different datasets.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Coefficient of Variation (CV) is the appropriate measure for comparing the relative variability of different datasets because it standardizes the measure of dispersion relative to the mean, allowing for meaningful comparisons across different datasets.</span></p>",
    "correct_choice_id": 40851,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11080,
    "choices": [
      {
        "id": 44286,
        "text": "<p><span style=\"font-size:12.0pt;\">Randomization</span></p>"
      },
      {
        "id": 44287,
        "text": "<p><span style=\"font-size:12.0pt;\">Blinding</span></p>"
      },
      {
        "id": 44288,
        "text": "<p><span style=\"font-size:12.0pt;\">Restriction</span></p>"
      },
      {
        "id": 44289,
        "text": "<p><span style=\"font-size:12.0pt;\">Matching</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">As a researcher designing a clinical study, you are exploring methods to eliminate confounding variables, which can lead to spurious associations between the independent and dependent variables. Which of the following methods is NOT primarily used to eliminate confounders? (AIIMS MAY 2019)</span></p>",
    "unique_key": "Q4818582",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305516,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Blinding</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This method is used primarily to prevent bias in the conduct and interpretation of clinical research.</span></li><li><span style=\"font-size:12pt;\">Blinding can be of participants, investigators, or those assessing outcomes, to ensure that the behaviors and evaluations are not influenced by knowledge of which treatment or intervention participants receive.</span></li><li><span style=\"font-size:12pt;\">While blinding reduces bias, it does not specifically address the issue of confounding variables.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Randomization:</strong> By randomly assigning participants to different groups in a study, randomization aims to evenly distribute confounding variables across all groups, thus reducing their potential impact on the outcome. This helps ensure that any differences observed between groups can more reliably be attributed to the intervention itself rather than to external variables.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Restriction:</strong> This involves limiting the participants in a study to certain criteria, effectively isolating specific characteristics and reducing variation that could lead to confounding. For example, a study may restrict participants to a certain age range, gender, or health status to control for these variables.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Matching:</strong> Matching involves pairing participants in the treatment group with similar participants in the control group based on certain characteristics (e.g., age, sex, baseline health status). This technique helps to ensure that the treatment and control groups are comparable on these characteristics, thereby controlling for confounding variables related to them.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Blinding is used to remove Bias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Confounding can be removed by:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Matching <strong>(MC used /simplest)</strong></span></li><li><span style=\"font-size:12.0pt;\">Randomisation <strong>(2nd Best Method)</strong></span></li><li><span style=\"font-size:12.0pt;\">Restriction</span></li><li><span style=\"font-size:12.0pt;\">Stratification</span></li><li><span style=\"font-size:12.0pt;\">Statistical Modelling / Multivariate analysis (MVA)</span></li><li><span style=\"font-size:12.0pt;\">Stratified Randomization (Overall Best Method)</span></li></ol>",
    "correct_choice_id": 44287,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11077,
    "choices": [
      {
        "id": 44274,
        "text": "<p><span style=\"font-size:12.0pt;\">Cholera</span></p>"
      },
      {
        "id": 44275,
        "text": "<p><span style=\"font-size:12.0pt;\">Typhoid</span></p>"
      },
      {
        "id": 44276,
        "text": "<p><span style=\"font-size:12.0pt;\">Polio</span></p>"
      },
      {
        "id": 44277,
        "text": "<p><span style=\"font-size:12.0pt;\">Tetanus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">As a public health expert, you are consulted about a series of outbreaks in a region that lacks significant prior vaccination campaigns. Given the imperative to contain the spread of disease and protect vulnerable populations, you are asked to prioritize a disease for which mass vaccination would provide the most immediate and impactful reduction in transmission. Which of the following diseases would most benefit from such an intervention? (AIIMS MAY 2019)</span></p>",
    "unique_key": "Q1161023",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305513,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Polio</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Mass immunization is one of the best strategies to deal with outbreak of poliomyelitis.</span></li><li><span style=\"font-size:12.0pt;\">Outbreak response immunization (ORI): Following the Acute flaccid paralysis case investigation and stool specimen collection, ORI is organized in community.</span></li><li><span style=\"font-size:12.0pt;\">Children aged 0-59 months are given one dose of OPV regardless of previous immunization (in the village/locality of the AFP case)</span></li><li><span style=\"font-size:12.0pt;\">Travel history of the child with AFP may suggest additional places of stay where ORI should also be conducted</span></li><li><span style=\"font-size:12.0pt;\">Atleast 500 children are vaccinated</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Options A. Cholera:&nbsp;</strong>In case of a <strong>cholera</strong> outbreak, the most effective response would be chemoprophylaxis for a household or a closed community and. Drug of choice for chemoprophylaxis is Tetracycline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Typhoid:</strong> control in case of an outbreak includes health education, water quality and sanitation improvement, prevent carriers from handling food, milk or water from others, and training of health professionals in diagnosis and treatment. Vaccination is not advised for typhoid outbreaks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tetanus</strong>: Tetanus is not a communicable disease in the traditional sense as it does not spread from person to person. Instead, it is caused by bacteria entering the body through wounds. Thus, mass vaccination for tetanus isn't typically utilized as an outbreak response but is important in routine immunization schedules.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Polio, due to its potential for rapid spread and severe outcomes, along with the availability of an effective and easily administered vaccine, makes it the most critical focus for a mass vaccination campaign in response to an outbreak.</span></li><li><span style=\"font-size:12.0pt;\">This strategy not only protects individuals but also aids in the global effort to eradicate polio.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Outbreak response for Measles includes</strong></span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:12.0pt;\">Isolation for 7 days after the onset of rash</span></li><li><span style=\"font-size:12.0pt;\">Immunization of the contacts within 2 days of exposure (if vaccine is contraindicated, immunoglobulins should be given within 3-4 days of exposure)</span></li><li><span style=\"font-size:12.0pt;\">Prompt immunization at the beginning of an epidemic is essential to limit the spread.</span></li></ol>",
    "correct_choice_id": 44276,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "Factual"
    ]
  },
  {
    "id": 10252,
    "choices": [
      {
        "id": 40974,
        "text": "<p><span style=\"font-size:12.0pt;\">Testing all the dogs for rabies</span></p>"
      },
      {
        "id": 40975,
        "text": "<p><span style=\"font-size:12.0pt;\">Reduce stray dog population and vaccinate all dogs</span></p>"
      },
      {
        "id": 40976,
        "text": "<p><span style=\"font-size:12.0pt;\">Strengthening laboratory facilities</span></p>"
      },
      {
        "id": 40977,
        "text": "<p><span style=\"font-size:12.0pt;\">Increase capacity of healthcare workers for surveillance</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">While numerous animals play a role in the transmission of rabies, dogs stand out as the most common ones. Moreover, the impact of this disease is often more in children. Given this understanding, what approach would be both economically efficient and rational to reduce the occurrence of rabies?</span>(NEET PG 2022)</p>",
    "unique_key": "Q1173197",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305538,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Reduce stray dog population and vaccinate all dogs</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Since dogs are the primary source of infection, the most cost-effective (and logical) strategy would be Elimination of stray dogs and taking a step towards mass immunization. This approach directly addresses the primary source of infection and helps break the transmission cycle of the rabies virus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;<strong>Testing all the dogs for rabies:&nbsp;</strong>Not economically efficient due to the large number of dogs and the high cost of testing. It also does not prevent the spread of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;<strong>Strengthening laboratory facilities:&nbsp;</strong>While important for diagnosis and monitoring, this does not address the primary prevention of rabies through vaccination and control of the dog population.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>Increase capacity of healthcare workers for surveillance:&nbsp;</strong>Surveillance is crucial but does not directly prevent rabies transmission. It is more of a reactive approach rather than a proactive prevention strategy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Reducing the stray dog population and vaccinating all dogs is the most economically efficient and rational approach to reduce the occurrence of rabies. This strategy directly targets the primary source of infection and helps prevent the spread of the disease.</span></p>",
    "correct_choice_id": 40975,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10253,
    "choices": [
      {
        "id": 40978,
        "text": "<p><span style=\"font-size:12.0pt;\">Therapeutic assessment</span></p>"
      },
      {
        "id": 40979,
        "text": "<p><span style=\"font-size:12.0pt;\">Physical</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">assessment</span></p>"
      },
      {
        "id": 40980,
        "text": "<p><span style=\"font-size:12.0pt;\">Biochemical</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">assessment</span></p>"
      },
      {
        "id": 40981,
        "text": "<p><span style=\"font-size:12.0pt;\">Behavioral</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">assessment</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following steps is not included in WHO's STEP approach?(NEET &nbsp;PG 2022)</span></p>",
    "unique_key": "Q9476006",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305539,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Therapeutic assessment</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">STEPwise approach to surveillance (STEPS) is a simple, standardized method by WHO for surveillance. It is of two types:</span><ul><li><span style=\"font-size:12.0pt;\">STEPwise approach to chronic disease risk factor surveillance</span></li><li><span style=\"font-size:12.0pt;\">STEPwise approach to Stroke surveillance</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/04/screenshot-2023-10-04-121523.jpg\" alt=\"\" width=\"800\" height=\"453\"></span></p>",
    "correct_choice_id": 40978,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10704,
    "choices": [
      {
        "id": 42782,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cost effective analysis</span></span></span></p>"
      },
      {
        "id": 42783,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cost benefit analysis</span></span></span></p>"
      },
      {
        "id": 42784,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Network analysis</span></span></span></p>"
      },
      {
        "id": 42785,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Input Output analysis</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In which of the following analyses is monetary benefit quantified? (NEET PG 2020)</span></span></p>",
    "unique_key": "Q5135151",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305519,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Cost benefit analysis </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cost Benefit Analysis (CBA):</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> CBA is a method used to evaluate the total costs versus the total benefits of a project or decision in monetary terms. It helps determine whether the benefits of a project or decision outweigh the costs, thereby justifying the investment. This type of analysis assigns a monetary value to all outcomes, allowing for a direct comparison between costs and benefits. For example, the National Tuberculosis Elimination Program (NTEP) might report that it saved $12 million in a given year.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Cost Effective Analysis (CEA): Definition:</span></strong><span style=\"font-size:12.0pt\"> CEA assesses the relative costs and outcomes (effects) of different courses of action.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Output:</span></strong><span style=\"font-size:12.0pt\"> It is measured in non-monetary terms such as health outcomes (e.g., quality-adjusted life years (QALY) saved). For instance, the NTEP might measure its effectiveness by the number of lives saved or the improvement in the quality of life.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Network Analysis: Definition:</span></strong><span style=\"font-size:12.0pt\"> This is a quantitative method that involves mapping out and analyzing the sequence of activities and events in a project.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Tools:</span></strong><span style=\"font-size:12.0pt\"> It includes techniques like Program Evaluation and Review Technique (PERT) and Critical Path Method (CPM).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Usage:</span></strong><span style=\"font-size:12.0pt\"> Network analysis is used to identify the sequence of tasks, the longest path through the project (critical path), and to optimize the project schedule.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Input Output Analysis: Definition:</span></strong><span style=\"font-size:12.0pt\"> This method examines the relationship between inputs and outputs in an economic system.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Application:</span></strong><span style=\"font-size:12.0pt\"> It can include both cost-benefit and cost-effective analyses as it calculates the effects of changing inputs on the outputs. This type of analysis is often used in economics to understand how different sectors of an economy interact.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:31px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:31px\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CBA [Cost Benefit Analysis] - </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Results of a program analyzed in terms of MONETARY benefits, e.g. NTEP (2023-24) saved 12 m US $</span></span></span></p>\r\n\r\n<p style=\"margin-right:31px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:31px\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CEA [Cost Effective Analysis] - </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Output of a program analyzed in terms of RESULTS eg. NTEP (2023-24) save 1.7 Million people can be determined with help of QALY.</span></span></span></p>\r\n\r\n<p style=\"margin-right:31px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:31px\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">INPUT-OUTPUT ANALYSIS - </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calculation of effects of changing the inputs (Includes CBA &amp; CEA)</span></span></span></p>\r\n\r\n<p style=\"margin-right:31px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:31px\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NETWORK ANALYSIS &ndash; </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is a quantitative method. It includes activities &amp; events. PERT is sequence of activities. CPM is the longest path in PERT.</span></span></span></p>",
    "correct_choice_id": 42783,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11066,
    "choices": [
      {
        "id": 44230,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Pulmonary TB</span></p>"
      },
      {
        "id": 44231,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">CNS and disseminated TB</span></p>"
      },
      {
        "id": 44232,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Pulmonary and CNS TB</span></p>"
      },
      {
        "id": 44233,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Pulmonary and skeletal TB</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">You are counseling a new mother about the importance of immunization for her newborn. She is particularly interested in understanding the BCG vaccine's benefits, as she has heard conflicting opinions from friends and family. Based on current evidence and guidelines, which of the following best describes the primary protective effects of the BCG vaccine in the context of tuberculosis (TB)? </span><span style=\"color:black;font-size:12.0pt;\">(AIIMS MAY 2018)</span></p>",
    "unique_key": "Q3659743",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305502,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) CNS and disseminated TB&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">BCG vaccine provides protection against CNS and disseminated TB.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>BCG Vaccine</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">LIVE, Attenuated, Lyophilised vaccine</span></li><li><span style=\"color:black;font-size:12.0pt;\">Reconstituent \u2013 NORMAL SALINE</span></li><li><span style=\"color:black;font-size:12.0pt;\">Strain&nbsp;DANISH\u20131331 (VIA M. BOVIS, 239 SC FOR 13 YR)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Dose&nbsp;0.05 (upto 28 days, then 0.1 ml) ID, just above insertion of left deltoid</span></li><li><span style=\"color:black;font-size:12.0pt;\">Efficacy&nbsp;0-80% (MEDIAN-50%)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Dose&nbsp;at birth, 1 TU in 0.1 ml</span></li><li><span style=\"color:black;font-size:12.0pt;\">20 years protection {No protection against pulmonary TB}</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture9222.jpg\" alt=\"\" width=\"200\" height=\"341\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The BCG vaccine is primarily recommended for its effectiveness in preventing severe forms of tuberculosis, such as CNS and disseminated TB, in children.</span></li></ul>",
    "correct_choice_id": 44231,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 10258,
    "choices": [
      {
        "id": 40998,
        "text": "<p><span style=\"font-size:12.0pt;\">1000 for mother and 400 for ASHA</span></p>"
      },
      {
        "id": 40999,
        "text": "<p><span style=\"font-size:12.0pt;\">1400 for mother and 600 for ASHA</span></p>"
      },
      {
        "id": 41000,
        "text": "<p><span style=\"font-size:12.0pt;\">600 for mother and 400 for ASHA</span></p>"
      },
      {
        "id": 41001,
        "text": "<p><span style=\"font-size:12.0pt;\">400 for mother and 600 for ASHA&nbsp;&nbsp;&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In an urban area in the state of Madhya Pradesh, a first-time pregnant woman visits a healthcare facility for her delivery following encouragement from an ASHA worker. What monetary advantages will they obtain under the Janani Suraksha Yojana? (NEET PG 2022)</span></p>",
    "unique_key": "Q4817121",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305544,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 1000 for mother and 400 for ASHA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Under the Janani Suraksha Yojana (JSY), a cash incentive scheme, pregnant women who deliver in healthcare facilities are provided financial assistance. The scheme aims to reduce maternal and neonatal mortality by promoting institutional delivery among poor pregnant women.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Madhya Pradesh is categorized as a Low Performing State (LPS), the incentives are as follows:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Mother's Package:</strong> \u20b91000</span></li><li><span style=\"font-size:12.0pt;\"><strong>ASHA's Package:</strong> \u20b9400</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: &nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-124528.png\" alt=\"\" width=\"1000\" height=\"246\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">(LPS: Low performing states; HPS: High performing states)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">(LPS include UP, Uttarakhand, MP, Jharkhand, Bihar, Chhattisgarh, Odisha, Assam, Jammu &amp; Kashmir, Rajasthan)</span></p>",
    "correct_choice_id": 40998,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11074,
    "choices": [
      {
        "id": 44262,
        "text": "<p><span style=\"font-size:12.0pt;\">Malaria slide preparation</span></p>"
      },
      {
        "id": 44263,
        "text": "<p><span style=\"font-size:12.0pt;\">Ensure immunization as per schedule</span></p>"
      },
      {
        "id": 44264,
        "text": "<p><span style=\"font-size:12.0pt;\">Accompany pregnant women to hospital</span></p>"
      },
      {
        "id": 44265,
        "text": "<p><span style=\"font-size:12.0pt;\">Spread aware</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">You are posted as a medical officer in a rural Primary Health Centre (PHC) for your rural internship. As part of your duties, you are required to oversee and understand the roles and responsibilities of ASHA working in your region. Which of the following tasks is NOT traditionally a responsibility of the ASHA worker? (AIIMS MAY 2019)</span></p>",
    "unique_key": "Q9691330",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305510,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Malaria slide preparation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">ASHA (Accredited Social Health Activist) workers play a crucial role in community health, especially in rural areas of India.</span></li><li><span style=\"font-size:12.0pt;\">Their responsibilities are extensive but focused primarily on preventive and promotive healthcare. But not the malaria slides preparation.</span></li><li><span style=\"font-size:12.0pt;\">Preparation of malaria slides is the responsibility of health worker male.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other 3 options are ASHA responsibilities</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Responsibilities of ASHA:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Create awareness on health and its social determinants and mobilize the community towards local health planning and increased utilization and accountability of the existing health services</span></li><li><span style=\"font-size:12.0pt;\">Promote good health practices and provide a minimum package of curative care as appropriate and feasible and make timely referrals</span></li><li><span style=\"font-size:12.0pt;\">Provide information on determinants of health, on existing health services and the need for timely utilization of services</span></li><li><span style=\"font-size:12.0pt;\">Counsel women on aspects of reproductive and child health</span></li><li><span style=\"font-size:12.0pt;\">Mobilize the community and facilitate them in accessing health and health related services provided by the government</span></li><li><span style=\"font-size:12.0pt;\">Act as a depot holder for essential provisions like ORS, IFA tablets, chloroquine, disposable delivery kits, oral pills &amp; condoms</span></li><li><span style=\"font-size:12.0pt;\">Provide primary medical care and act as DOTS provider</span></li><li><span style=\"font-size:12.0pt;\">Help develop a comprehensive village health plan</span></li><li><span style=\"font-size:12.0pt;\">Arrange escort/accompany pregnant women and children requiring treatment/ admission to nearest health facility</span></li><li><span style=\"font-size:12.0pt;\">Be a part of JSY (Janani Suraksha Yojana) and help reduce MMR</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Proposed population norm</strong>: 2 ASHA worker per 1000 population</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>ASHA is expected to act as,</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Interface between: Community and Health care system</span></li><li><span style=\"font-size:12.0pt;\">Bridge between: ANM and village</span></li><li><span style=\"font-size:12.0pt;\">Accountable to: Panchayat</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Selection criteria of ASHA:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Woman resident of local community</span></li><li><span style=\"font-size:12.0pt;\">Preferably 25 \u2013 45 years age</span></li><li><span style=\"font-size:12.0pt;\">Literate with formal education up to 10th class (Relaxable for Tribal areas)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Indicators for Monitoring and Evaluation of ASHA\u2019s Work</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Process indicators:</span><ul><li><span style=\"font-size:12.0pt;\">No. of ASHAs selected</span></li><li><span style=\"font-size:12.0pt;\">No. of ASHAs trained</span></li><li><span style=\"font-size:12.0pt;\">% ASHAs attending review meeting after 1 year</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Outcome indicators:</span><ul><li><span style=\"font-size:12.0pt;\">% newborns weighed and families counseled</span></li><li><span style=\"font-size:12.0pt;\">% deliveries with skilled assistance</span></li><li><span style=\"font-size:12.0pt;\">% institutional deliveries</span></li><li><span style=\"font-size:12.0pt;\">% JSY claims made to ASHA</span></li><li><span style=\"font-size:12.0pt;\">Completed immunized 12-23 months age group</span></li><li><span style=\"font-size:12.0pt;\">% unmet need in BPL</span></li><li><span style=\"font-size:12.0pt;\">% fever cases received chloroquine within 1 weeks in endemic area</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Impact indicators:</span><ul><li><span style=\"font-size:12.0pt;\">Infant mortality rate (IMR)</span></li><li><span style=\"font-size:12.0pt;\">Child malnutrition rates</span></li><li><span style=\"font-size:12.0pt;\">No. of cases of TB/Leprosy detected as compared to last year.</span></li></ul></li></ul>",
    "correct_choice_id": 44262,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11068,
    "choices": [
      {
        "id": 44238,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Screening for cervical cancer</span></span></span></p>"
      },
      {
        "id": 44239,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Providing services for unmarried mothers</span></span></span></p>"
      },
      {
        "id": 44240,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Screening for HIV infection</span></span></span></p>"
      },
      {
        "id": 44241,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Providing adoption services</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 24-year-old woman visits a clinic in Mumbai for a consultation about family planning. She discusses various options and services with her healthcare provider. During the conversation, she asks about additional health screenings included in family planning services. Which of the following screenings is NOT typically included as part of family planning services in India? (AIIMS MAY 2019)</span></span></p>",
    "unique_key": "Q6041994",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305504,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Screening for HIV infection</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Family planning services aim to support individuals and couples in managing their reproductive health, but not all health screenings are integrated into these services:</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Screening for HIV infection:</span></strong><span style=\"font-size:12.0pt\"> This screening, while crucial for overall health and particularly important in prenatal care to prevent mother-to-child transmission, is generally conducted as part of broader sexual health services rather than within the narrower scope of family planning services.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Screening for cervical cancer:</span></strong><span style=\"font-size:12.0pt\"> This is typically included because it directly relates to reproductive health and can impact a woman&rsquo;s long-term health and fertility.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Providing services for unmarried mothers:</span></strong><span style=\"font-size:12.0pt\"> This includes counseling and support, reflecting a comprehensive approach to reproductive health care that supports all individuals, regardless of marital status.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Providing adoption services:</span></strong><span style=\"font-size:12.0pt\"> Part of family planning services that helps individuals and couples prepare for parenthood, including the option of adoption, aligning with the broad goals of family planning.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Family planning is not synonymous with birth control only. A WHO Expert Committee (1970) recommends that family planning includes in its&rsquo; purview:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Proper spacing and limitation of birth</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Advice on sterility</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Education for parenthood</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sex education</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Screening for pathological conditions related to the reproductive system (e.g., cervical cancer)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Genetic counselling</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Premarital consultation and examination</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pregnancy tests</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Marriage counselling</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Preparation of couples for the first child</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Providing services to unmarried mothers</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Teaching home economics and nutrition</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Providing adoption services</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 44240,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 10207,
    "choices": [
      {
        "id": 40794,
        "text": "<p><span style=\"font-size:12.0pt;\">180- 220</span></p>"
      },
      {
        "id": 40795,
        "text": "<p><span style=\"font-size:12.0pt;\">160- 240</span></p>"
      },
      {
        "id": 40796,
        "text": "<p><span style=\"font-size:12.0pt;\">170- 230</span></p>"
      },
      {
        "id": 40797,
        "text": "<p><span style=\"font-size:12.0pt;\">190- 210</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In a study involving a population, where the mean value is 200, if the standard deviation is 20, 68% of the population will lie between? (NEET PG 2020)</span></p>",
    "unique_key": "Q2078083",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305531,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 180-220</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a Normal/Gaussian/Standard Distribution curve,</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. B/L Symmetrical Bell shaped curve</span></p><p><span style=\"font-size:12.0pt;\">2. Mean = Median = Mode \u00e0 Known as coincidence</span></p><p><span style=\"font-size:12.0pt;\">3. If Mean = 0 in Normal Distribution, then SD is 1</span></p><p><span style=\"font-size:12pt;\">4. Mean \u00b1 1SD \u2192Covers 68% value [68.3%]</span></p><p><span style=\"font-size:12pt;\">5. Mean \u00b1 2SD \u2192Covers 95% value [95.4%]</span></p><p><span style=\"font-size:12pt;\">6. Mean \u00b1 3SD \u2192Covers 99% value [99.7%]</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">So, 68% population will cover, Mean \u00b1 1SD.</span></p><p><span style=\"font-size:12.0pt;\">Mean = 200</span></p><p><span style=\"font-size:12.0pt;\">Standard Deviation = 20</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>68% population will lie between = 200 \u00b1 20 = 180 - 220</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-151255.png\" alt=\"\" width=\"500\" height=\"320\"></strong></span></p>",
    "correct_choice_id": 40794,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11076,
    "choices": [
      {
        "id": 44270,
        "text": "<p><span style=\"font-size:12.0pt;\">Prospective Cohort</span></p>"
      },
      {
        "id": 44271,
        "text": "<p><span style=\"font-size:12.0pt;\">Ambispective Cohort</span></p>"
      },
      {
        "id": 44272,
        "text": "<p><span style=\"font-size:12.0pt;\">Case control</span></p>"
      },
      {
        "id": 44273,
        "text": "<p><span style=\"font-size:12.0pt;\">Cross sectional</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">You are participating in a research discussion about the best approach to study the circadian changes in the fat content of expressed breast milk among mothers of preterm babies. The primary aim is to observe the variations over time and establish a temporal relationship. Which of the following study designs would be most suitable to achieve this objective? (AIIMS MAY 2019)</span></p>",
    "unique_key": "Q9840192",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305512,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Prospective Cohort</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The study design of choice for the given scenario is a prospective study.</span></li><li><span style=\"font-size:12.0pt;\">In the given situation, the study cohort would comprise of mothers with preterm infants, whereas the control cohort would include mothers with full-term babies.</span></li><li><span style=\"font-size:12.0pt;\">To investigate the diurnal fluctuations in the fat composition of expressed breast milk, samples of breast milk would be collected at designated time points each day.</span></li><li><span style=\"font-size:12.0pt;\">These samples would be monitored over the course of multiple days and subjected to analysis. This research constitutes a prospective study.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Ambispective Cohort:</strong> An Ambispective cohort includes both retrospective and prospective cohort study. This case scenario will not fit in retrospective study</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Case control:</strong> Case-control study is also a retrospective study.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cross sectional:</strong> Cross-sectional study is used to figure out the prevalence of a disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A prospective cohort study is the optimal design for research that needs to observe how a variable changes over time and establish a chronological sequence of events or effects. This method will allow for the systematic collection of breast milk samples at various times to analyze changes in fat content relative to the time of day in a defined sample of mothers with preterm infants.</span></li></ul>",
    "correct_choice_id": 44270,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 11075,
    "choices": [
      {
        "id": 44266,
        "text": "<p><span style=\"font-size:12.0pt;\">COV of DBP is more than Vitamin D</span></p>"
      },
      {
        "id": 44267,
        "text": "<p><span style=\"font-size:12.0pt;\">COV of Vitamin D is more than DBP</span></p>"
      },
      {
        "id": 44268,
        "text": "<p><span style=\"font-size:12.0pt;\">Both DBP and Vitamin D have equal variability</span></p>"
      },
      {
        "id": 44269,
        "text": "<p><span style=\"font-size:12.0pt;\">It cannot be ascertained from information provided</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">During your clinical rotations, you are reviewing data from an experiment that examined the correlation between Vitamin D levels and diastolic blood pressure (DBP). The experiment aimed to ascertain the variability within two distinct sample sets. Based on the findings, the average DBP was noted to be 110, with an associated standard deviation of 11. Similarly, the mean Vitamin D level was observed to be 18, with a standard deviation of 3. With reference to the coefficient of variation (COV), which statement accurately represents the collected data? (AIIMS MAY 2019)</span></p>",
    "unique_key": "Q5980809",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305511,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) COV of Vitamin D is more than DBP</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Coefficient of Variation (COV)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Is a measure used to compare relative variability</span></li><li><span style=\"font-size:12.0pt;\">Is a unit-free measure to compare dispersion of one variable with another</span></li><li><span style=\"font-size:12.0pt;\">Is SD expressed as percentage of mean</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/screenshot-2023-10-23-125116.jpg\" alt=\"\" width=\"300\" height=\"51\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Calculation -</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">COV of DBP = 11/110 = 0.1</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">COV of Vitamin D = 3/18 = 0.166</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hence, COV of Vitamin D is more than DBP</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The coefficient of variation provides a useful comparison of variability across different datasets.</span></li><li><span style=\"font-size:12.0pt;\">In this case, the higher COV for Vitamin D indicates a greater relative variation compared to DBP, highlighting important considerations for researchers analyzing the impacts or associations involving these variables.</span></li></ul>",
    "correct_choice_id": 44267,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 10210,
    "choices": [
      {
        "id": 40806,
        "text": "<p><span style=\"font-size:12.0pt;\">Sulfur dioxide, smoke, and suspended particles</span></p>"
      },
      {
        "id": 40807,
        "text": "<p><span style=\"font-size:12.0pt;\">Sulfur dioxide, lead, and particulate matter</span></p>"
      },
      {
        "id": 40808,
        "text": "<p><span style=\"font-size:12.0pt;\">Sulfur dioxide and carbon monoxide</span></p>"
      },
      {
        "id": 40809,
        "text": "<p><span style=\"font-size:12.0pt;\">Carbon monoxide and hydrogen sulfide</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The most effective markers for air pollution surveillance include: (NEET PG 2020)</span></p>",
    "unique_key": "Q3384498",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305528,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>ns. A) Sulfur dioxide, smoke, and suspended particles</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The best indicators for air pollution surveillance are sulfur dioxide, smoke, and suspended particles.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Overall best Air Pollution Indicator - SO2</span></li><li><span style=\"font-size:12.0pt;\">Overall best chemical Indicator of Air Pollution - SO2</span></li><li><span style=\"font-size:12.0pt;\">Best biological Indicator of Air Pollution \u2192 LICHENS</span></li><li><span style=\"font-size:12.0pt;\">Air Pollution Monitoring \u2192 CPCB [Central Pollution Control Board]</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-160349.jpg\" alt=\"\" width=\"570\" height=\"400\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most effective markers for air pollution surveillance include sulfur dioxide, smoke, and suspended particles. These provide a comprehensive assessment of air quality and are crucial for monitoring the impact on health and the environment.</span></p>",
    "correct_choice_id": 40806,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11036,
    "choices": [
      {
        "id": 44110,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Alpha error</span></p>"
      },
      {
        "id": 44111,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Beta error</span></p>"
      },
      {
        "id": 44112,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">1-\u03b1</span></p>"
      },
      {
        "id": 44113,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">1-\u03b2</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dr. Sharma was enthusiastically reviewing the results of a randomized controlled trial (RCT) that aimed to compare the therapeutic benefits of Drug A and Drug B. To her surprise, the data suggested a statistically significant difference between the two medications, indicated by a p-value of &lt;0.005. However, after a comprehensive review and collaboration with other experts, it was established that in real-world settings, both drugs had essentially equivalent therapeutic outcomes. This error in interpretation, where a difference was falsely identified when none existed in reality, is best described by which of the following statistical terms? (AIIMS MAY 2017)</span></p>",
    "unique_key": "Q9569090",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305480,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. A) Alpha error</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">In the given scenario, null hypothesis (H<sub>0</sub>) can be that the two drugs being the same in effectiveness is true in reality.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The alternative hypothesis will be that both drugs are different.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Since P-value was found to be &lt; 0.005, means that data is statistically significant and thus, null hypothesis is rejected.</span></li><li><span style=\"color:black;font-size:12.0pt;\">But it is already established that the null hypothesis is true and now if we accept the alternative hypothesis even though it is false, this will be a type I error or alpha error.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Hypothesis (H): Is an assumption about the status of a phenomenon</span></li><li><span style=\"color:black;font-size:12.0pt;\">Null Hypothesis (H<sub>0</sub>): In Biostatistics, when we have to prove a particular hypothesis about difference between 2 regimens, we make Null Hypothesis (For examples, If we have to prove that new treatment is better than older treatment, H<sub>0</sub> = new treatment is not better than older treatment).</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Statistical errors:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/screenshot-2023-10-18-114514.jpg\" alt=\"\" width=\"800\" height=\"183\"></strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Type I Error (Alpha Error):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Null hypothesis is true but rejected</span></li><li><span style=\"color:black;font-size:12.0pt;\">Probability of Type I error is given by \u2018P \u2013 value\u2019 (probability of declaring a significant difference when actually it is not present)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Significance (a) level: is the maximum tolerable probability of Type I error</span></li><li><span style=\"color:black;font-size:12.0pt;\">Alpha is fixed in advance: P \u2013 value calculated can be less than, equal to or greater than alpha (a)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Keep Type I error to be minimum (P &lt; a): Then results are declared statistically significant</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Type II Error (Beta Error):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Null hypothesis is false but not rejected (or accepted)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Probability of Type II error is given by beta (b) (probability of declaring no significant difference when actually it is present)</span></li></ul>",
    "correct_choice_id": 44110,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 10217,
    "choices": [
      {
        "id": 40834,
        "text": "<p><span style=\"font-size:12.0pt;\">&lt;70</span></p>"
      },
      {
        "id": 40835,
        "text": "<p><span style=\"font-size:12.0pt;\">&lt;100</span></p>"
      },
      {
        "id": 40836,
        "text": "<p><span style=\"font-size:12.0pt;\">&lt;50</span></p>"
      },
      {
        "id": 40837,
        "text": "<p><span style=\"font-size:12.0pt;\">&lt;130</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Within the framework of Sustainable Development Goal 3, the objective of target 3.1 is to achieve a reduction in the Maternal Mortality Ratio to what specific level (per 1 lakh live births) by the year 2030? (NEET PG 2020)</span></p>",
    "unique_key": "Q6130945",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305523,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) &lt;70</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In Sustainable Development Goal 3, the target 3.1 aims to reduce the Maternal Mortality Ratio by 2030 to &lt;70 per 1 lakh live births.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-173901.jpg\" alt=\"\" width=\"716\" height=\"442\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>SDGs \u2013 Targets &amp; Indicators</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">3.1 - By 2030, MMR &lt; 70</span></p><p><span style=\"font-size:12.0pt;\">3.2 - By 2030, NNMR 12 &amp; U5MR 25</span></p><p><span style=\"font-size:12.0pt;\">3.3 - By 2030, end epidemics of AIDS, TB, Malaria and NTDs and combat Hepatitis, Water-borne diseases and other CDS.</span></p><p><span style=\"font-size:12.0pt;\">3.4 - By 2030, reduce by 1/3 premature mortality from NCDs.</span></p><p><span style=\"font-size:12.0pt;\">3.5 - Strengthen the prevention &amp; treatment of substance abuse.</span></p><p><span style=\"font-size:12.0pt;\">3.6 - By 2020, halve the global deaths and injuries form RTA.</span></p><p><span style=\"font-size:12.0pt;\">3.7 - By 2030, universal access to Sexual &amp; Rep \u2013 health care services.</span></p><p><span style=\"font-size:12.0pt;\">3.8 - Achieve Universal health coverage.</span></p><p><span style=\"font-size:12.0pt;\">3.9 - By 2030, reduce the number of deaths, illnesses form hazardous chemicals and air, water and soil pollution and contamination.</span></p>",
    "correct_choice_id": 40834,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10212,
    "choices": [
      {
        "id": 40814,
        "text": "<p><span style=\"font-size:12.0pt;\">Cardiovascular</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">diseases</span></p>"
      },
      {
        "id": 40815,
        "text": "<p><span style=\"font-size:12.0pt;\">Cervical Cancer</span></p>"
      },
      {
        "id": 40816,
        "text": "<p><span style=\"font-size:12.0pt;\">Breast Cancer</span></p>"
      },
      {
        "id": 40817,
        "text": "<p><span style=\"font-size:12.0pt;\">Road</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Traffic</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">Accidents</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The scope of Project MONICA includes: (NEET PG 2020</span></p>",
    "unique_key": "Q6338313",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305526,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cardiovascular diseases&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Project MONICA is related to cardiovascular diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The WHO MONICA (<strong>MONI</strong>toring trends and determinants in <strong>CA</strong>rdiovascular disease) Project was designed to measure trends and determinants in cardiovascular disease mortality and coronary heart disease and cerebrovascular disease morbidity, and to assess the extent to which these trends are related to changes in known risk factors in different populations in 27 countries (10 years\u2019 period)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The scope of Project MONICA is focused on cardiovascular diseases, specifically monitoring trends in coronary heart disease and cerebrovascular disease and examining the impact of various risk factors on these conditions.</span></p>",
    "correct_choice_id": 40814,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11046,
    "choices": [
      {
        "id": 44150,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">0.66/10,000 population</span></p>"
      },
      {
        "id": 44151,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">0.66/1 lakh population</span></p>"
      },
      {
        "id": 44152,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">9.7/10,000 population</span></p>"
      },
      {
        "id": 44153,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">9.7/1 lakh population</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dr. Mehta, Public health expert who works extensively with the National Leprosy Eradication Programme (NLEP) in India. In a meeting with local health workers in 2017, he has shared the data and progress made in controlling leprosy. He mentions the crucial statistic of the Annual New Case Detection Rate (ANCDR) as of March 31, 2016, to give a snapshot of the magnitude of new leprosy cases detected. This rate helps in understanding the effectiveness of ongoing programs and strategies. What value did Dr. Mehta share as the ANCDR for leprosy for that specific year? (AIIMS MAY 2017)</span></p>",
    "unique_key": "Q6529952",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305485,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) 9.7/1 lakh population</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">During the 2015-2016 period, India recorded an annual new case detection rate (ANCDR) for leprosy at 9.7 per 100,000 people.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Annual New Case Detection Rate (ANCDR):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">An important Indicator being used under the National Leprosy Eradication Program&nbsp;</span></li><li><span style=\"color:black;font-size:12.0pt;\">Indicator is calculated at the end of March every year, wherein New Cases detected during the</span><span style=\"font-size:12.0pt;\"> </span><span style=\"color:black;font-size:12.0pt;\">period April (Previous Calendar year) and March (current year) is used</span></li><li><span style=\"color:black;font-size:12.0pt;\">ANCDR - 2015-16: 9.71 per 100,000 population</span></li><li><span style=\"color:black;font-size:12.0pt;\"><strong>ANCDR - 2021-22: 5.52 per 100,000 population</strong></span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The ANCDR is a pivotal indicator in disease surveillance and control programs, helping public health officials and stakeholders understand the scale of new cases and the impact of interventions.</span></li><li><span style=\"font-size:12.0pt;\">For leprosy in India, maintaining a keen understanding of this rate is essential for achieving the goals of the National Leprosy Eradication Programme.</span></li></ul>",
    "correct_choice_id": 44153,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11044,
    "choices": [
      {
        "id": 44142,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Azithromycin + Metronidazole</span></p>"
      },
      {
        "id": 44143,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Cefixime + Azithromycin</span></p>"
      },
      {
        "id": 44144,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Azithromycin + Doxycycline</span></p>"
      },
      {
        "id": 44145,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Doxycycline + Cefixime</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dr. Rajan is a consultant at a primary health center, frequently encountering cases of sexually transmitted infections (STIs) and reproductive tract infections (RTIs). He usually prefers syndromic approach for managing these conditions due to limited diagnostic facilities. A 28-year-old male patient walks in, presenting with discharge from his urethra, indicating a possible urethritis. The patient is unaware of the specific causative organism. Given the syndromic management approach, which combination of medications would Dr. Rajan most likely prescribe to effectively treat both gonococcal and non-gonococcal urethritis? (AIIMS MAY 2017)</span></p>",
    "unique_key": "Q5084789",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305484,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) Cefixime + Azithromycin</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">&nbsp;According to the syndromic approach for managing STIs/RTIs, the preferred treatment for both gonococcal and non-gonococcal urethritis involves a combination of Azithromycin and Cefixime.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-114908.png\" alt=\"\" width=\"1000\" height=\"514\"></p>",
    "correct_choice_id": 44143,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 10208,
    "choices": [
      {
        "id": 40798,
        "text": "<p><span style=\"font-size:12.0pt;\">Blood bag</span></p>"
      },
      {
        "id": 40799,
        "text": "<p><span style=\"font-size:12.0pt;\">Gloves</span></p>"
      },
      {
        "id": 40800,
        "text": "<p><span style=\"font-size:12.0pt;\">Sharp</span></p>"
      },
      {
        "id": 40801,
        "text": "<p><span style=\"font-size:12.0pt;\">Urine bag</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is disposed in the yellow bag? (NEET PG 2020)</span></p>",
    "unique_key": "Q3494932",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305530,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Blood bag</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Blood bag is disposed in the yellow bag.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Gloves:&nbsp;</strong>Red</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">bag.</span></p><p>&nbsp;</p><p><br><span style=\"font-size:12.0pt;\"><strong>Option C. &nbsp;Sharps:</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">White container.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Urine bags:&nbsp;</strong>Red bag.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-151616.png\" alt=\"\" width=\"1000\" height=\"1271\"></p>",
    "correct_choice_id": 40798,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11035,
    "choices": [
      {
        "id": 44106,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Yellow \u2013 least priority</span></p>"
      },
      {
        "id": 44107,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Red \u2013 mortality</span></p>"
      },
      {
        "id": 44108,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Green \u2013 ambulatory</span></p>"
      },
      {
        "id": 44109,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Blue \u2013 ambulatory</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">During a major disaster response, the medical team in an emergency department needs to prioritize patients based on the severity of their injuries and their medical needs. This prioritization process is known as triage. Each patient is assigned a specific color code representing their current state and the urgency of their medical attention. Which of the following correctly matches the color designation with its corresponding level of patient priority in the triage process? (AIIMS MAY 2017)</span></p>",
    "unique_key": "Q3185412",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305479,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. C) Green \u2013 ambulatory</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Triage is a critical process used in emergency medicine to quickly classify patients according to the severity of their health condition and the urgency of their need for care.</span></li><li><span style=\"font-size:12.0pt;\">The color-coding system is a standardized approach used globally, with each color representing a specific category of priority:</span></li><li><span style=\"font-size:12.0pt;\"><strong>Green</strong> indicates \"ambulatory\" patients, who are those with relatively minor injuries or conditions that do not require immediate, life-saving intervention.</span></li><li><span style=\"font-size:12.0pt;\">These patients can often walk and may have injuries such as infections, closed fractures, minor abrasions, and lacerations.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/screenshot-2023-10-18-114302.jpg\" alt=\"\" width=\"800\" height=\"417\"></strong></span></p>",
    "correct_choice_id": 44108,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "CriteriaBased"
    ]
  },
  {
    "id": 10200,
    "choices": [
      {
        "id": 40766,
        "text": "<p><span style=\"font-size:12.0pt;\">1 year</span></p>"
      },
      {
        "id": 40767,
        "text": "<p><span style=\"font-size:12.0pt;\">2 years</span></p>"
      },
      {
        "id": 40768,
        "text": "<p><span style=\"font-size:12.0pt;\">3 years</span></p>"
      },
      {
        "id": 40769,
        "text": "<p><span style=\"font-size:12.0pt;\">4 years</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An employee who has been diagnosed with tuberculosis is eligible for an extended sickness benefit for? (NEET PG 2020)</span></p>",
    "unique_key": "Q3100071",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305536,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2 years</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Under the Employees' State Insurance (ESI) Act of 1948, employees who are diagnosed with specific long-term illnesses, including tuberculosis, are eligible for an extended sickness benefit. This benefit provides financial support to cover a significant portion of their wages during prolonged periods of illness. The extended sickness benefit offers 80% of the employee's wages for up to 2 years. This provision ensures that employees have continued financial support while they are unable to work due to their medical condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-134020.jpg\" alt=\"\" width=\"1000\" height=\"318\"></span></p>",
    "correct_choice_id": 40767,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10205,
    "choices": [
      {
        "id": 40786,
        "text": "<p><span style=\"font-size:12.0pt;\">Chi Square test</span></p>"
      },
      {
        "id": 40787,
        "text": "<p><span style=\"font-size:12.0pt;\">Paired T test</span></p>"
      },
      {
        "id": 40788,
        "text": "<p><span style=\"font-size:12.0pt;\">Standard error of the mean</span></p>"
      },
      {
        "id": 40789,
        "text": "<p><span style=\"font-size:12.0pt;\">ANOVA</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An investigation was conducted to evaluate the nutritional status of young children residing in both rural and urban regions. Among the participants, 30 children from rural areas and 20 children from urban areas were found to be malnourished. Which of the following tests of significance is the most appropriate in this case? (NEET PG 2020)</span></p>",
    "unique_key": "Q9021115",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305533,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Chi Square test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Chi Square test can be used to determine whether there is a significant association or relationship between two categorical variables. In this case, the two variables are the nutritional status (malnourished or not malnourished) and the location (rural or urban), both of which are Qualitative characters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/03/screenshot-2023-10-03-160346.jpg\" alt=\"\" width=\"700\" height=\"358\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Paired T test:&nbsp;</strong> is used when comparing the means of two related samples, such as before and after measurements for the same group.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;Standard error of the mean:&nbsp;</strong> is a measure of the variability of sample means.</span></p><p>&nbsp;</p><p><strong>Option D.&nbsp;</strong><span style=\"font-size:14.6667px;\">&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>ANOVA:&nbsp;</strong></span><span style=\"font-size:12pt;\"> is used to compare the means of three or more groups.</span></p><p><span style=\"font-size:12.0pt;\">These tests are not appropriate for analyzing the relationship between two categorical variables as in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Chi Square test is the appropriate statistical test for evaluating the association between two categorical variables, such as nutritional status (malnourished vs. not malnourished) and location (rural vs. urban).</span></p>",
    "correct_choice_id": 40786,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11031,
    "choices": [
      {
        "id": 44090,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Urine bag</span></span></span></span></p>"
      },
      {
        "id": 44091,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Anatomical waste</span></span></span></span></p>"
      },
      {
        "id": 44092,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Soiled waste</span></span></span></span></p>"
      },
      {
        "id": 44093,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Sharp waste</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 56-year-old woman was admitted to a tertiary care hospital in New Delhi following a fall at home. During her stay, the nursing staff consistently followed protocols for waste segregation. Based on the guidelines for biomedical waste management, which type of waste should be correctly disposed of in the following mentioned bag? (AIIMS MAY 2017)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip1.jpg\" style=\"height:325px; width:300px\" /></p>",
    "unique_key": "Q1850145",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305476,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A) Urine Bag</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-111930.png\" style=\"height:741px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"margin-right:-3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:63px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option B. Anatomical waste:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Anatomical wastes is disposed in yellow bin.</span></span></span></span></p>\r\n\r\n<p style=\"margin-right:63px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:63px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option C. Soiled waste:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Soiled wastes are disposed in yellow bin.</span></span></span></span></p>\r\n\r\n<p style=\"margin-right:63px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option D. Sharp waste:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Sharp wastes are disposed in white puncture proof, leak-proof, tamper-proof white containers.</span></span></span></span></p>\r\n\r\n<p style=\"margin-right:-3px\">&nbsp;</p>\r\n\r\n<p style=\"margin-right:-3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-3px\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The red biohazard bag is used for the disposal of </span><span style=\"font-size:12.0pt\"><span style=\"color:black\">Contaminated plastic recyclable waste like tubing, bottles, intravenous tubes and sets, catheters, urine bags, syringes (without needles) and gloves</span></span></span></span></li>\r\n</ul>",
    "correct_choice_id": 44090,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 11063,
    "choices": [
      {
        "id": 44218,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Red bin</span></p>"
      },
      {
        "id": 44219,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Yellow bin</span></p>"
      },
      {
        "id": 44220,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Blue bin</span></p>"
      },
      {
        "id": 44221,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Black bin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">According to the current biomedical waste management guidelines, which colored bin should be used </span><span style=\"color:black;font-size:12.0pt;\">for the disposal of blood bag? (AIIMS MAY 2018)</span></p>",
    "unique_key": "Q6703405",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305499,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) Yellow bin&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Yellow Bin:</strong> Used for human and animal anatomical waste, soiled waste, expired or discarded medicines, chemical waste, and clinical lab waste.</span></li><li><span style=\"font-size:12.0pt;\">This includes items such as body parts, blood bags, and items contaminated with body fluids.</span></li><li><span style=\"font-size:12.0pt;\">The disposal methods typically involve incineration, plasma pyrolysis, deep burial, or chemical treatment.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/category222.jpg\" alt=\"\" width=\"800\" height=\"1080\"></p>",
    "correct_choice_id": 44219,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 10255,
    "choices": [
      {
        "id": 40986,
        "text": "<p><span style=\"font-size:12.0pt;\">Green tea increases the risk of diabetes</span></p>"
      },
      {
        "id": 40987,
        "text": "<p><span style=\"font-size:12.0pt;\">Green tea decreases the risk of diabetes</span></p>"
      },
      {
        "id": 40988,
        "text": "<p><span style=\"font-size:12.0pt;\">Data insufficient to establish causal association</span></p>"
      },
      {
        "id": 40989,
        "text": "<p><span style=\"font-size:12.0pt;\">The value (0.84) tends to be close to 1, hence there is no effect</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A cohort study was carried out involving individuals who consumed green tea and those who did not, aiming to examine its impact on diabetes mellitus. The calculated risk ratio stood at 0.84. Which of the subsequent statements is accurate?&nbsp;</span>(NEET PG 2022)</p>",
    "unique_key": "Q4665160",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305541,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Green tea decreases the risk of diabetes</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Green tea consumption decreases the risk of DM</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Relative risk &lt;1 implies negative/inverse association, i.e., risk factor is rather protective for the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The risk ratio of 0.84 indicates that the incidence of diabetes mellitus is lower in the group of drinkers of green tea compared to the group of non-drinkers. Therefore, it can be concluded that green tea decreases the risk of diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Relative risk (RR) = Incidence among exposed/Incidence among non-exposed</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-103632.png\" alt=\"\" width=\"1000\" height=\"192\"></strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Note - Strength of association in a cohort study is evaluated by:\u2013 Relative risk, Attributable risk (AR), Population attributable risk (PAR)</strong></span></p>",
    "correct_choice_id": 40987,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11069,
    "choices": [
      {
        "id": 44242,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"ES\" style=\"font-size:12.0pt\">Kala azar</span></span></span></p>"
      },
      {
        "id": 44243,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"ES\" style=\"font-size:12.0pt\">Oriental sore</span></span></span></p>"
      },
      {
        "id": 44244,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oraya fever</span></span></span></p>"
      },
      {
        "id": 44245,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Trench Fever</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following diseases is NOT transmitted by sandflies? (AIIMS MAY 2019)</span></span></p>",
    "unique_key": "Q8894596",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305505,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Trench fever</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Trench fever is transmitted by lice and caused by Bartonella quintana.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Points to remember about Sandfly -&nbsp;</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sandfly cannot fly; it hops</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sandfly rests in cracks and crevices of walls</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Insecticide of choice:&nbsp;</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">DDT - 2 rounds of spray per year; Spray up to 6 feet height on walls;&nbsp;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">If DDT&ndash;resistant, use BHC&nbsp;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sandfly is the vector of:</span></span></span></li>\r\n</ul>\r\n\r\n<ul style=\"list-style-type:circle; margin-left:40px\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Visceral Leishmaniasis (Kala azar) (by Female Phlebotamus argentipes)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cutaneous Leishmaniasis (Oriental Sore) &amp; Mucocutaneous Leishmaniasis (by Phlebotamus papatasi &amp; Phlebotamus sergenti)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sandfly Fever</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oroya Fever</span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sandflies inject the infective stage, metacyclic promastigotes, during blood meals.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/screenshot-2023-10-23-124402.jpg\" style=\"height:240px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/screenshot-2023-10-23-124435.jpg\" style=\"height:252px; width:300px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/screenshot-2023-10-23-124503.jpg\" style=\"height:743px; width:900px\" /></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vectors and Diseases Transmitted</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-151633.png\" style=\"height:604px; width:1000px\" /></span></span></span></p>",
    "correct_choice_id": 44245,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11054,
    "choices": [
      {
        "id": 44182,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Age and serum cholesterol level</span></p>"
      },
      {
        "id": 44183,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Heart rate and body mass index</span></p>"
      },
      {
        "id": 44184,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Sex and type of cancer</span></p>"
      },
      {
        "id": 44185,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Weight of a patient before and after a treatment</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">You are working on a research project and need to determine the appropriate usage of the Chi-square test. </span><span style=\"color:black;font-size:12.0pt;\">Which of the following sets of data would be most appropriate for utilizing the Chi-square test? (AIIMS MAY 2018)</span></p>",
    "unique_key": "Q4355063",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305490,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. C) Sex and type of cancer</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">The chi-square test is a nonparametric statistical method used to evaluate the significance of an association between two categorical variables.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Within the provided choices, the only pair of categorical variables (qualitative data) is sex and type of cancer. Therefore, this is the correct answer.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/222.jpg\" alt=\"\" width=\"900\" height=\"484\"></span></p>",
    "correct_choice_id": 44184,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ]
  },
  {
    "id": 11061,
    "choices": [
      {
        "id": 44210,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Type II error is small and we can accept the findings of the study</span></p>"
      },
      {
        "id": 44211,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">The probability of false negative conclusion that operation A is better than B is 4%</span></p>"
      },
      {
        "id": 44212,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">The power of the study to detect the difference between operation A and B is 96%</span></p>"
      },
      {
        "id": 44213,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">The probability of a false positive conclusion that operation A is better than B is 4%</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">During a journal club discussion on a randomized controlled trial comparing two surgical techniques for direct inguinal hernia, the reported p-value is 0.04. What is the most accurate interpretation of this p-value? </span><span style=\"color:black;font-size:12.0pt;\">(AIIMS MAY 2018)</span></p>",
    "unique_key": "Q3024671",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305497,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) The probability of a false positive conclusion that operation A is better than B is 4%</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">With a calculated p-value of 0.04, we can deduce that there is a 4% chance of arriving at a false positive conclusion, suggesting that operation A is superior to operation B.</span></li><li><span style=\"color:black;font-size:12.0pt;\">In this context, the p-value of 0.04 attains statistical significance by conventional standards.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Consequently, we have grounds to reject the null hypothesis and accept the alternative hypothesis, indicating that operation A outperforms operation B.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A p-value of 0.04 suggests that there is a statistically significant difference, at the 5% significance level, between the surgical techniques being compared, assuming the risk of a false positive conclusion is acceptable at 4%.</span></li></ul>",
    "correct_choice_id": 44213,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 10257,
    "choices": [
      {
        "id": 40994,
        "text": "<p><span style=\"font-size:12.0pt;\">Puncture proof blue bin&nbsp;</span></p>"
      },
      {
        "id": 40995,
        "text": "<p><span style=\"font-size:12.0pt;\">White container</span></p>"
      },
      {
        "id": 40996,
        "text": "<p><span style=\"font-size:12.0pt;\">Yellow</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">container</span></p>"
      },
      {
        "id": 40997,
        "text": "<p><span style=\"font-size:12.0pt;\">Red container</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What is the proper disposal method for a damaged vaccine vial according to biomedical waste management protocols? (NEET PG 2022)</span></p>",
    "unique_key": "Q6199701",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305543,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Puncture proof blue bin&nbsp;</strong></span></p><p style=\"margin-left:85px;\"><span style=\"font-size:10.5pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Blue puncture proof container</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Under BMW guidelines, Glassware and Metallic Body Implants are disposed in Cardboard boxes with blue colored marking/ puncture proof bins. These bins are specifically designed to safely handle glass and metallic body implants to prevent injury and ensure proper disposal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/19/screenshot-2024-09-19-124303.png\" alt=\"\" width=\"1000\" height=\"1267\"></p>",
    "correct_choice_id": 40994,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 10254,
    "choices": [
      {
        "id": 40982,
        "text": "<p><span style=\"font-size:12.0pt;\">Cured</span></p>"
      },
      {
        "id": 40983,
        "text": "<p><span style=\"font-size:12.0pt;\">Treatment</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">completed</span></p>"
      },
      {
        "id": 40984,
        "text": "<p><span style=\"font-size:12.0pt;\">Lost to follow up</span></p>"
      },
      {
        "id": 40985,
        "text": "<p><span style=\"font-size:12.0pt;\">Treatment</span> <span style=\"font-size:12.0pt;\">failed</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A male patient who was diagnosed with tuberculosis has successfully completed the full course of treatment. Subsequent to finishing both the intensive and continuation phases, the initial sputum examination was conducted. The results of this examination were negative. What is the current condition of the patient?</span>&nbsp;(NEET PG 2022)</p>",
    "unique_key": "Q4093473",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305540,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cured</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A patient with negative sputum examination at the end of tuberculosis treatment indicates that the patient has been cured of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis that primarily affects the lungs and causes pulmonary tuberculosis.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">A TB case can be confirmed by positive results on smear microscopy and culture of biological specimens or diagnosed clinically by a clinician who prescribes a full course of TB treatment.</span></li><li><span style=\"font-size:12.0pt;\">TB treatment consists of two phases: the intensive phase lasting for two months and the continuation phase lasting for four months.</span></li><li><span style=\"font-size:12.0pt;\">Treatment involves four drugs in the intensive phase, namely isoniazid, rifampicin, pyrazinamide, and ethambutol, and isoniazid along with rifampicin and ethambutol in the continuation phase.</span></li><li><span style=\"font-size:12.0pt;\">After completion of treatment, the patient's sputum/culture is tested and assigned one of the following outcomes: cured, treatment completed, treatment failed, lost to follow-up, died, or not evaluated, depending on the results of the test and the patient's medical history.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;<strong>Treatment Completed:&nbsp;</strong>Refers to a patient who has completed treatment without evidence of failure but lacks documented negative sputum smear or culture results in the last month of treatment and on at least one previous occasion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;<strong>Lost to Follow-Up:&nbsp;</strong>Refers to a patient who did not start treatment or whose treatment was interrupted for two consecutive months or more.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>Treatment Failed:&nbsp;</strong>Refers to a patient whose sputum smear or culture is still positive after 5 months or more of treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Terminologies:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Cured -</strong> A TB patient whose smear or culture turned negative in the last month of treatment and on at least one previous occasion</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment completed -</strong> A TB patient who completed treatment without any failure, but has no record to show that sputum smear or culture results in the last month of treatment and on at least one previous occasion were negative; it may be either because tests were not done or because results are unavailable</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment failed -</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">A TB patient whose sputum smear or culture is still positive after treatment for 5 months or more</span></li><li><span style=\"font-size:12.0pt;\"><strong>Lost to follow-up</strong> - A TB patient who did not start treatment or whose treatment was interrupted for 2 consecutive months or more</span></li><li><span style=\"font-size:12.0pt;\"><strong>Died -</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">A TB patient who dies before starting or during the course of treatment for any reason</span></li><li><span style=\"font-size:12.0pt;\"><strong>Not evaluated -</strong> A TB patient for whom no treatment outcome is assigned; this includes cases \"transferred out\" to another treatment unit and cases for whom the treatment outcome is unknown to the reporting unit whose treatment is interrupted</span></li></ul>",
    "correct_choice_id": 40982,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11079,
    "choices": [
      {
        "id": 44282,
        "text": "<p><span style=\"font-size:12.0pt;\">y=10-\u0445</span></p>"
      },
      {
        "id": 44283,
        "text": "<p><span style=\"font-size:12.0pt;\">x=10+\u0443</span></p>"
      },
      {
        "id": 44284,
        "text": "<p><span style=\"font-size:12.0pt;\">y=11+2x</span></p>"
      },
      {
        "id": 44285,
        "text": "<p><span style=\"font-size:12.0pt;\">x=11+2y</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In a clinical study exploring the relationship between variables X and Y, a scatter plot with a linear regression line has been generated. Based on the graphical representation provided, which of the following equations corresponds to the linear regression model of the plotted graph?<strong> </strong>(AIIMS MAY 2019)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip13.jpg\" alt=\"\" width=\"400\" height=\"258\"></span></p>",
    "unique_key": "Q8065377",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305515,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) y=11+2x</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Y = 11 + 2x is a simple linear regression equation where a = 11 and b = 2 are constants and x and y are variables.</span></li><li><span style=\"font-size:12.0pt;\">Regression is change in measurements of a variable. It provides structure of relationship between 2 quantitative variables.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Types of regressions:</span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Simple linear regression: Only one dependent variable and one independent variable</span></li><li><span style=\"font-size:12.0pt;\">Multiple linear regression: Only one dependent variable and more than one independent variable</span></li><li><span style=\"font-size:12.0pt;\">Simple curvilinear regression: Only one dependent variable and one independent variable, with some power of independent variable</span></li><li><span style=\"font-size:12.0pt;\">Multiple curvilinear regression: Only one dependent variable and more than one independent variables, with some power of independent variables).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Types of regression equations:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/screenshot-2023-10-23-125240.jpg\" alt=\"\" width=\"700\" height=\"286\"></span></p>",
    "correct_choice_id": 44284,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "ImageBased",
      "InvestigationBased"
    ]
  },
  {
    "id": 11052,
    "choices": [
      {
        "id": 44174,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\"><span style=\"color:black\">Artemether plus lumefantrine</span></span></span></span></p>"
      },
      {
        "id": 44175,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\"><span style=\"color:black\">Artesunate plus Sulfadoxine plus pyrimethamine</span></span></span></span></p>"
      },
      {
        "id": 44176,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\"><span style=\"color:black\">Chloroquine</span></span></span></span></p>"
      },
      {
        "id": 44177,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Mefloquine</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">A 28-year-old man from west Garo Hill district of Meghalaya presents to the Civil Hospital with intermittent fever, chills, and malaise. Laboratory findings confirm the diagnosis of P. falciparum malaria. The region is known for its Multidrug- resistant strains of P. falciparum. Which of the following antimalarial regimens is considered the most appropriate first-line treatment for P. falciparum malaria in areas with multidrug-resistant strains? (AIIMS MAY 2018)</span></span></span></p>",
    "unique_key": "Q8980812",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305488,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A) Artemether plus lumefantrine</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The Drug of choice treatment for Plasmodium falciparum infection in North Eastern states is artemether + lumefantrine</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">ARTEMISINS - ARTESUNATE AND ARTEMETHER</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Fastest acting anti-malarial</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Effective against MDR parasites</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Short acting</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">C/I in 1st trimester</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">&nbsp;Artemisinin Combination Therapy [ACT]</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Artemisin + Long acting drug</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">DOC for chloroquine resistant malaria Combinations</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Artemether + Lumefantrine: DOC in North Eastern States</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Artesunate + Sulfadoxine-Pyrimethamine: DOC for rest of India</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The dose of artesunate is 200 mg OD for 3 days whereas sulfadoxine (1500 mg) and pyrimethamine (75 mg) should be taken on day 1 only)</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Educational Objective: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For P. falciparum malaria in regions with known drug resistance, artemether plus lumefantrine is the most effective first-line treatment, ensuring rapid and sustained clearance of the malaria parasite.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 44174,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 57607,
    "choices": [
      {
        "id": 229797,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Artesunate 50 mg (4 tablets) + Primaquine 2.5 mg (6 tablets)</span></span></span></p>"
      },
      {
        "id": 229798,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Artesunate 50 mg (4 tablets) + Primaquine 7.5 mg (6 tablets)</span></span></span></p>"
      },
      {
        "id": 229799,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Artesunate 50 mg (4 tablets) + Sulphadoxine/Pyrimethamine 750/37.5 mg (2 tablets) + Primaquine 2.5 mg (6 tablets)</span></span></span></p>"
      },
      {
        "id": 229800,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Artesunate 50 mg (4 tablets) + Sulphadoxine/Pyrimethamine 750/37.5 mg (2 tablets) + Primaquine 7.5 mg (6 tablets)</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 32-year-old man from Rajasthan is diagnosed with mixed malaria infection &ndash; P. falciparum + P. vivax. Treatment regimen on Day 2 would be:</span><span style=\"font-size:12.0pt\"> (NEET PG 2024)</span></span></span></p>",
    "unique_key": "Q9165910",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305570,
    "difficulty_level": "difficult",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Artesunate 50 mg (4 tablets) + Primaquine 2.5 mg (6 tablets)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In cases of mixed malaria infection involving P. falciparum and P. vivax, the treatment approach differs from that of single-species infections. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For mixed infections, the primaquine dose is adjusted to 2.5 mg to target both liver and blood stages effectively, while artesunate is used to clear the parasitemia. Artesunate is typically given for three consecutive days, and the dosage of primaquine is reduced compared to when treating only P. falciparum, where the standard dose would be 7.5 mg. This regimen helps in managing mixed malaria effectively, ensuring both species are adequately targeted.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Note &ndash; </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For patients from other parts of the country, <strong>ACT-SP</strong> (artesunate + sulfadoxine-pyrimethamine) plus <strong>primaquine</strong> is used.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For patients from <strong>northeast India</strong>, <strong>artemether-lumefantrine</strong> combination therapy is preferred.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Primaquine</span></strong><span style=\"font-size:12.0pt\"> in mixed infections is given for <strong>14 days</strong>, while in single infections, it is given only on the <strong>second day</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In mixed malaria infections involving P. falciparum and P. vivax, primaquine 2.5 mg is used on Day 2 along with artesunate to effectively treat both species.</span></span></p>",
    "correct_choice_id": 229797,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11039,
    "choices": [
      {
        "id": 44122,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">1/3 of the total protein requirement + \u00bd of total energy requirement</span></p>"
      },
      {
        "id": 44123,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">2/3 of the total protein requirement + \u00bd of total energy requirement</span></p>"
      },
      {
        "id": 44124,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">\u00bd of the total protein requirement + 1/3 of total energy requirement</span></p>"
      },
      {
        "id": 44125,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">\u00bd of the total protein requirement + 2/3 of total energy requirement</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dr. Anil, working as a nutritional consultant with the government of India, is reviewing the Mid-Day Meal (MDM) scheme, an initiative to enhance the nutritional intake among school-going children. He emphasizes that the nutritional component of the meals should not just be about filling stomachs but ensuring that children get adequate protein and energy to support their growth and learning. Given the constraints and the need to ensure minimal nutritional adequacy, what should the minimum supplementation be in the Mid-Day Meal to support the children's needs? (AIIMS MAY 2017)</span></p>",
    "unique_key": "Q7571574",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305482,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. C) \u00bd of the total protein requirement + 1/3 of total energy requirement</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">The meal should supplement 1/3 of the total energy requirement and 1/2 of the total protein requirement.</span></li><li><span style=\"color:black;font-size:12.0pt;\"><strong>Mid-day meal programme (MDMP):&nbsp;</strong>Also known as \u2018School Lunch Programme\u2019, it has been in operation since 1961.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The <strong>major objective&nbsp;</strong>of MDMP: To attract more children for admission to schools and retain them so that literacy improvement of children could be brought about.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The meal is a supplement and not a substitute to the home diet</span></li><li><span style=\"color:black;font-size:12.0pt;\">The meal should supply 1/3 of the total energy requirement and 1/2 of the total protein requirement</span></li><li><span style=\"color:black;font-size:12.0pt;\">MDMP is being operationalised under the Ministry of Human Resource &amp; Development&nbsp;</span></li><li><span style=\"color:black;font-size:12.0pt;\">National Institute of Nutrition, Hyderabad is of the view that minimum number of feeding days in year be 250 to have the desired impact on children</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Mid-day meal scheme (MDMS) (National Programme of Nutritional Support to Primary Education):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Launched in 1995</span></li><li><span style=\"color:black;font-size:12.0pt;\">Main objective: Universalisation of primary education by increasing enrolment, retention and attendance and simultaneously impacting on nutrition of students in primary classes</span></li><li><span style=\"color:black;font-size:12.0pt;\">The mid-day meal should supply 1/3 of the total energy requirement and 1/2 of the total protein requirement</span></li><li><span style=\"color:black;font-size:12.0pt;\">A model menu for mid-day school meal</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/whatsapp-image-2023-10-18-at-122126.jpeg\" alt=\"\" width=\"800\" height=\"294\"></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Principles for formulating mid-day meals:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Meal should be a supplement only not a substitute for home diet</span></li><li><span style=\"color:black;font-size:12.0pt;\">Meal should provide 1/3 calories and 1/2 proteins</span></li><li><span style=\"color:black;font-size:12.0pt;\">Meal cost should be low</span></li><li><span style=\"color:black;font-size:12.0pt;\">Complicated cooking process must not be involved</span></li><li><span style=\"color:black;font-size:12.0pt;\">Use locally available foods</span></li><li><span style=\"color:black;font-size:12.0pt;\">Keep changing menu frequently</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Mid-Day Meal Scheme is now renamed as PM POSHAN or Pradhan Mantri Poshan Shakti Nirman.</strong></span></p>",
    "correct_choice_id": 44124,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "CriteriaBased",
      "Factual"
    ]
  },
  {
    "id": 11073,
    "choices": [
      {
        "id": 44258,
        "text": "<p><span style=\"font-size:12.0pt;\">100</span></p>"
      },
      {
        "id": 44259,
        "text": "<p><span style=\"font-size:12.0pt;\">10</span></p>"
      },
      {
        "id": 44260,
        "text": "<p><span style=\"font-size:12.0pt;\">250</span></p>"
      },
      {
        "id": 44261,
        "text": "<p><span style=\"font-size:12.0pt;\">160</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A drug trial was initiated under Medicine department to test the efficacy of a new medication in comparison to a placebo. The participants were divided into two cohorts. Cohort A received a placebo, while cohort B was treated with the novel drug. Out of the 120 participants in cohort A, 36 faced fatal outcomes. In cohort B, with 130 participants, there were 26 fatal outcomes. Given this data, if a clinician were to incorporate this novel medication into practice, how many patients would they need to treat with this new medication to prevent one additional fatality when compared to the placebo group? (AIIMS MAY 2019)</span></p>",
    "unique_key": "Q2312613",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305509,
    "difficulty_level": "intermediate",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 10</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">10 patients need to be treated with the new drug to avert 1 death.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">We can group divide the case scenario into two groups:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Experimental (New treatment) group \u2013 26 Treatment failures out of 130</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Control (Old treatment) group \u2013 36 Treatment failures out of 120</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/screenshot-2023-10-23-124705.jpg\" alt=\"\" width=\"700\" height=\"184\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Now, we have to calculate failure rate in both groups:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Experimental (New treatment) group \u2013 26/130 = 0.2</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Control (Old treatment) group \u2013 36/120 = 0.3</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">&nbsp;<strong>Absolute risk reduction (ARR) </strong>is the difference of failure in both groups = 0.3 \u2013 0.2 = 0.1</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Number needed to treat (NNT) = 1/ARR </strong>= 1/0.1 = 10</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The Number Needed to Treat (NNT) is a practical measure used in decision-making for clinical interventions.</span></li><li><span style=\"font-size:12.0pt;\">It represents the number of patients that need to be treated with a particular therapy over a specific period to prevent one additional bad outcome, such as death in this scenario.</span></li><li><span style=\"font-size:12.0pt;\">An NNT of 10 indicates that the new medication has a significant impact in reducing fatalities compared to the placebo.</span></li></ul>",
    "correct_choice_id": 44259,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 11048,
    "choices": [
      {
        "id": 44158,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">600 kcal/day</span></p>"
      },
      {
        "id": 44159,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">520 kcal/day</span></p>"
      },
      {
        "id": 44160,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">450 kcal/day</span></p>"
      },
      {
        "id": 44161,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">350 kcal/day</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dr. Rathi, an obstetrician in a suburban Indian clinic, was counseling Mrs. Mehta, a software engineer, on nutritional needs during pregnancy. Mrs. Mehta has a sedentary desk job and is entering her second trimester. The doctor emphasized the significance of an appropriate caloric intake to ensure both maternal and fetal health. Given her lifestyle and the stage of pregnancy, by how much should Mrs. Mehta ideally increase her daily caloric consumption? (AIIMS MAY 2017)</span></p>",
    "unique_key": "Q9924590",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305486,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) 350 kcal/day</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\">The suggested daily calorie intake for a pregnant woman in a sedentary occupation should be raised by approximately 350 calories.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/whatsapp-image-2023-10-18-at-122347.jpeg\" alt=\"\" width=\"800\" height=\"183\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\"><strong>Pregnancy Additional Energy Requirements:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"color:black;font-size:12.0pt;\">+350 kcal/day</span></li></ul></li><li><span style=\"color:black;font-size:12.0pt;\"><strong>Lactation Additional Energy Requirements:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"color:black;font-size:12.0pt;\">0-6 m: +600 kcal/day</span></li><li><span style=\"color:black;font-size:12.0pt;\">6-12 m: +520 kcal/day</span></li></ul></li></ul>",
    "correct_choice_id": 44161,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 10214,
    "choices": [
      {
        "id": 40822,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypochlorite ion</span></p>"
      },
      {
        "id": 40823,
        "text": "<p><span style=\"font-size:12.0pt;\">Hydrochloric acid</span></p>"
      },
      {
        "id": 40824,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypochlorous acid</span></p>"
      },
      {
        "id": 40825,
        "text": "<p><span style=\"font-size:12.0pt;\">Chloride ion</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which compound among the options is predominantly responsible for the disinfectant quality to bleaching powder? (NEET PG 2020)</span></p>",
    "unique_key": "Q3386133",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305525,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Hypochlorous acid</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The primary reason for the disinfectant ability of bleaching powder stems from the activity of hypochlorous acid, which is responsible for its effectiveness. It surpasses hypochlorite ions in effectiveness by a factor of 70-80.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;<strong>Hypochlorite Ion (OCl\u207b):</strong> While it does have disinfectant properties, it is much less effective compared to hypochlorous acid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;<strong>Hydrochloric Acid (HCl):</strong> This is a byproduct of the reaction between chlorine and water but does not contribute significantly to the disinfectant quality.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;<strong>Chloride Ion (Cl\u207b):</strong> This is also a byproduct of the disinfection process and does not play a direct role in the disinfectant action.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Bleaching powder (CaOCl</u><sub><u>2</u></sub><u>)</u></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">2.5 gms of bleaching powder is sufficient to disinfect 1000L of water.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mechanism of action:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">CHLORINE + IMPURITIES \u00e0 DESTRUCTION Add some additional Cl<sub>2</sub> [free residual Cl<sub>2</sub>]</span></li><li><span style=\"font-size:12.0pt;\">Main disinfecting action of chlorine in water is due to HYPOCHLOROUS ACID [HOCL] [90% of disinfection] + Hypochlorite ions [10% of disinfection]</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">H<sub>2</sub>O + Cl \u2192 HCI + HOCI HOCI \u2192 H + OCI</span></p>",
    "correct_choice_id": 40824,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "RecentNEETPG"
    ]
  },
  {
    "id": 11064,
    "choices": [
      {
        "id": 44222,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Safety</span></p>"
      },
      {
        "id": 44223,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Efficacy</span></p>"
      },
      {
        "id": 44224,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dose range</span></p>"
      },
      {
        "id": 44225,
        "text": "<p><span style=\"color:black;font-size:12.0pt;\">Pharmacoeconomics</span></p>"
      }
    ],
    "text": "<p><span style=\"color:black;font-size:12.0pt;\">A pharmaceutical company is in the early stages of developing a new antihypertensive medication. They are planning to conduct several phases of clinical trials to assess different aspects of the drug. As part of this process, the research team is set to embark on Phase 1 of the trial. In the context of clinical trial phases, what is the primary objective of this initial phase? (AIIMS MAY 2018)</span></p>",
    "unique_key": "Q9597576",
    "question_audio": null,
    "question_video": null,
    "map_id": 34305500,
    "difficulty_level": "beginner",
    "subjects_id": [
      7
    ],
    "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. A) Safety&nbsp;</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Phase 1 of clinical trials is critically important as it marks the first introduction of a new drug into human subjects.</span></li><li><span style=\"font-size:12.0pt;\">The primary focus during this phase is to evaluate the safety of the drug.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Key elements assessed in Phase 1 include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Safety &amp; Non-toxicity</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Maximum Tolerated Dose (MTD</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/phase-i_page_1.jpg\" alt=\"\" width=\"787\" height=\"1679\"></strong></span></p>",
    "correct_choice_id": 44222,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "InvestigationBased"
    ]
  }
];
        let quizName = 'Late Night PYQ (INICET, PSM-1)';
        let hierarchy = ["Cerebellum", "Late Night PYQ INICET"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        const urlParams = new URLSearchParams(window.location.search);
        currentQuestionIndex = Math.min(parseInt(urlParams.get('startAt')) || 0, questionsData.length - 1);

        function goBack() {
            if (isQuizCompleted || confirm('Are you sure you want to leave the quiz? Your progress will be lost.')) {
                window.history.back();
            }
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                setTimeout(processAnswer, 300);
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            setTimeout(showSolution, 1500);
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }
            
            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (!window.location.pathname.endsWith('custom_quiz.html')) {
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>